Infections with bacteria of the genus HAEMOPHILUS.
A genus of PASTEURELLACEAE that consists of several species occurring in animals and humans. Its organisms are described as gram-negative, facultatively anaerobic, coccobacillus or rod-shaped, and nonmotile.
A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII.
A species of HAEMOPHILUS that appears to be the pathogen or causative agent of the sexually transmitted disease, CHANCROID.
Vaccines or candidate vaccines containing antigenic polysaccharides from Haemophilus influenzae and designed to prevent infection. The vaccine can contain the polysaccharides alone or more frequently polysaccharides conjugated to carrier molecules. It is also seen as a combined vaccine with diphtheria-tetanus-pertussis vaccine.
Infections of the nervous system caused by bacteria of the genus HAEMOPHILUS, and marked by prominent inflammation of the MENINGES. HAEMOPHILUS INFLUENZAE TYPE B is the most common causative organism. The condition primarily affects children under 6 years of age but may occur in adults.
A type of H. influenzae isolated most frequently from biotype I. Prior to vaccine availability, it was a leading cause of childhood meningitis.
A species of gram-negative bacteria in the genus HAEMOPHILUS found, in the normal upper respiratory tract of SWINE.
Acute, localized autoinoculable infectious disease usually acquired through sexual contact. Caused by HAEMOPHILUS DUCREYI, it occurs endemically almost worldwide, especially in tropical and subtropical countries and more commonly in seaports and urban areas than in rural areas.
A species of gram-negative bacteria in the genus HAEMOPHILUS, ubiquitous in the human ORAL CAVITY and PHARYNX. It has low pathogenicity but is occasionally implicated in ENDOCARDITIS in humans.
A species of gram-negative bacteria (currently incertae sedis) causing multisystem disease in CATTLE.
Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.
Inflammation of the MIDDLE EAR including the AUDITORY OSSICLES and the EUSTACHIAN TUBE.
A genus of the family Chinchillidae which consists of three species: C. brevicaudata, C. lanigera, and C. villidera. They are used extensively in biomedical research.
Gram-negative aerobic cocci of low virulence that colonize the nasopharynx and occasionally cause MENINGITIS; BACTEREMIA; EMPYEMA; PERICARDITIS; and PNEUMONIA.
Proteins isolated from the outer membrane of Gram-negative bacteria.
Nonsusceptibility of a microbe to the action of ampicillin, a penicillin derivative that interferes with cell wall synthesis.
An envelope of loose gel surrounding a bacterial cell which is associated with the virulence of pathogenic bacteria. Some capsules have a well-defined border, whereas others form a slime layer that trails off into the medium. Most capsules consist of relatively simple polysaccharides but there are some bacteria whose capsules are made of polypeptides.
A genus of PASTEURELLACEAE described as gram-negative, nonsporeforming, nonmotile, facultative anaerobes. Most members are found both as pathogens and commensal organisms in the respiratory, alimentary, and genital tracts of animals.
Polysaccharides found in bacteria and in capsules thereof.
Immunoglobulins produced in a response to BACTERIAL ANTIGENS.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
Deoxyribonucleic acid that makes up the genetic material of bacteria.
Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognized by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection.
A species of gram-negative bacteria in the genus HAEMOPHILUS, causing respiratory tract disease in CHICKENS known as infectious coryza.
A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.
Substances that reduce the growth or reproduction of BACTERIA.
Inflammation of the lung parenchyma that is associated with PLEURISY, inflammation of the PLEURA.
Proteins found in any species of bacterium.
The heritable modification of the properties of a competent bacterium by naked DNA from another source. The uptake of naked DNA is a naturally occuring phenomenon in some bacteria. It is often used as a GENE TRANSFER TECHNIQUE.
The functional hereditary units of BACTERIA.
The space and structures directly internal to the TYMPANIC MEMBRANE and external to the inner ear (LABYRINTH). Its major components include the AUDITORY OSSICLES and the EUSTACHIAN TUBE that connects the cavity of middle ear (tympanic cavity) to the upper part of the throat.
Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Two or more vaccines in a single dosage form.
A fixed-ratio combination of amoxicillin trihydrate and potassium clavulanate.
Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins.
A family of coccoid to rod-shaped nonsporeforming, gram-negative, nonmotile, facultatively anaerobic bacteria that includes the genera ACTINOBACILLUS; HAEMOPHILUS; MANNHEIMIA; and PASTEURELLA.
The formaldehyde-inactivated toxin of Corynebacterium diphtheriae. It is generally used in mixtures with TETANUS TOXOID and PERTUSSIS VACCINE; (DTP); or with tetanus toxoid alone (DT for pediatric use and Td, which contains 5- to 10-fold less diphtheria toxoid, for other use). Diphtheria toxoid is used for the prevention of diphtheria; DIPHTHERIA ANTITOXIN is for treatment.
A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.
Inflammation of the epiglottis.
An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106)
Tetanus toxoid is a purified and chemically inactivated form of the tetanus toxin, used as a vaccine to induce active immunity against tetanus disease by stimulating the production of antibodies.
A vaccine consisting of DIPHTHERIA TOXOID; TETANUS TOXOID; and whole-cell PERTUSSIS VACCINE. The vaccine protects against diphtheria, tetanus, and whooping cough.
Nonsusceptibility of an organism to the action of penicillins.
Substances elaborated by bacteria that have antigenic activity.
Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN.
The natural bactericidal property of BLOOD due to normally occurring antibacterial substances such as beta lysin, leukin, etc. This activity needs to be distinguished from the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy, which is measured by a SERUM BACTERICIDAL TEST.
Physicochemical property of fimbriated (FIMBRIAE, BACTERIAL) and non-fimbriated bacteria of attaching to cells, tissue, and nonbiological surfaces. It is a factor in bacterial colonization and pathogenicity.
The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.
Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN.
Diseases of domestic swine and of the wild boar of the genus Sus.
The middle portion of the pharynx that lies posterior to the mouth, inferior to the SOFT PALATE, and superior to the base of the tongue and EPIGLOTTIS. It has a digestive function as food passes from the mouth into the oropharynx before entering ESOPHAGUS.
Process of determining and distinguishing species of bacteria or viruses based on antigens they share.
Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6)
Bacterial infections of the leptomeninges and subarachnoid space, frequently involving the cerebral cortex, cranial nerves, cerebral blood vessels, spinal cord, and nerve roots.
A genus of gram-negative, aerobic, coccoid bacteria whose organisms are part of the normal flora of the oropharynx, nasopharynx, and genitourinary tract. Some species are primary pathogens for humans.
The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host.
Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease.
Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
Schedule giving optimum times usually for primary and/or secondary immunization.
Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed)
Immunoelectrophoresis in which immunoprecipitation occurs when antigen at the cathode is caused to migrate in an electric field through a suitable medium of diffusion against a stream of antibody migrating from the anode as a result of endosmotic flow.
A species of gram-negative, aerobic BACTERIA. It is a commensal and pathogen only of humans, and can be carried asymptomatically in the NASOPHARYNX. When found in cerebrospinal fluid it is the causative agent of cerebrospinal meningitis (MENINGITIS, MENINGOCOCCAL). It is also found in venereal discharges and blood. There are at least 13 serogroups based on antigenic differences in the capsular polysaccharides; the ones causing most meningitis infections being A, B, C, Y, and W-135. Each serogroup can be further classified by serotype, serosubtype, and immunotype.
Techniques used in studying bacteria.
Change brought about to an organisms genetic composition by unidirectional transfer (TRANSFECTION; TRANSDUCTION, GENETIC; CONJUGATION, GENETIC, etc.) and incorporation of foreign DNA into prokaryotic or eukaryotic cells by recombination of part or all of that DNA into the cell's genome.
Inflammation of the middle ear with a clear pale yellow-colored transudate.
Infections with bacteria of the family MORAXELLACEAE.
A class of carrier proteins that bind to TRANSFERRIN. Many strains of pathogenic bacteria utilize transferrin-binding proteins to acquire their supply of iron from serum.
A thin leaf-shaped cartilage that is covered with LARYNGEAL MUCOSA and situated posterior to the root of the tongue and HYOID BONE. During swallowing, the epiglottis folds back over the larynx inlet thus prevents foods from entering the airway.
A suspension of formalin-inactivated poliovirus grown in monkey kidney cell tissue culture and used to prevent POLIOMYELITIS.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
Cell-surface components or appendages of bacteria that facilitate adhesion (BACTERIAL ADHESION) to other cells or to inanimate surfaces. Most fimbriae (FIMBRIAE, BACTERIAL) of gram-negative bacteria function as adhesins, but in many cases it is a minor subunit protein at the tip of the fimbriae that is the actual adhesin. In gram-positive bacteria, a protein or polysaccharide surface layer serves as the specific adhesin. What is sometimes called polymeric adhesin (BIOFILMS) is distinct from protein adhesin.
A species in the genus GARDNERELLA previously classified as Haemophilus vaginalis. This bacterium, also isolated from the female genital tract of healthy women, is implicated in the cause of bacterial vaginosis (VAGINOSIS, BACTERIAL).
Inflammation of the lung parenchyma that is associated with BRONCHITIS, usually involving lobular areas from TERMINAL BRONCHIOLES to the PULMONARY ALVEOLI. The affected areas become filled with exudate that forms consolidated patches.
Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE.
The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS.
Procedures for identifying types and strains of bacteria. The most frequently employed typing systems are BACTERIOPHAGE TYPING and SEROTYPING as well as bacteriocin typing and biotyping.
Semisynthetic broad-spectrum cephalosporin.
A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.
A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
Nonsusceptibility of bacteria to the action of CHLORAMPHENICOL, a potent inhibitor of protein synthesis in the 50S ribosomal subunit where amino acids are added to nascent bacterial polypeptides.
A funnel-shaped fibromuscular tube that conducts food to the ESOPHAGUS, and air to the LARYNX and LUNGS. It is located posterior to the NASAL CAVITY; ORAL CAVITY; and LARYNX, and extends from the SKULL BASE to the inferior border of the CRICOID CARTILAGE anteriorly and to the inferior border of the C6 vertebra posteriorly. It is divided into the NASOPHARYNX; OROPHARYNX; and HYPOPHARYNX (laryngopharynx).
A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.
The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species.
Purulent infections of the conjunctiva by several species of gram-negative, gram-positive, or acid-fast organisms. Some of the more commonly found genera causing conjunctival infections are Haemophilus, Streptococcus, Neisseria, and Chlamydia.
Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis.
Material coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus.
Thin, hairlike appendages, 1 to 20 microns in length and often occurring in large numbers, present on the cells of gram-negative bacteria, particularly Enterobacteriaceae and Neisseria. Unlike flagella, they do not possess motility, but being protein (pilin) in nature, they possess antigenic and hemagglutinating properties. They are of medical importance because some fimbriae mediate the attachment of bacteria to cells via adhesins (ADHESINS, BACTERIAL). Bacterial fimbriae refer to common pili, to be distinguished from the preferred use of "pili", which is confined to sex pili (PILI, SEX).
A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.
Acids, salts, and derivatives of clavulanic acid (C8H9O5N). They consist of those beta-lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. They have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects.
A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
Compounds based on ERYTHROMYCIN with the 3-cladinose replaced by a ketone. They bind the 23S part of 70S bacterial RIBOSOMES.
Pathological processes of the female URINARY TRACT and the reproductive system (GENITALIA, FEMALE).
A class of plasmids that transfer antibiotic resistance from one bacterium to another by conjugation.
Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease (ANEMIA, SICKLE CELL); skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits (notably DEAFNESS); and COMA. (From Miller et al., Merritt's Textbook of Neurology, 9th ed, p111)
Inflammation of the lung parenchyma that is caused by bacterial infections.
Bacterial proteins that share the property of binding irreversibly to PENICILLINS and other ANTIBACTERIAL AGENTS derived from LACTAMS. The penicillin-binding proteins are primarily enzymes involved in CELL WALL biosynthesis including MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE; PEPTIDE SYNTHASES; TRANSPEPTIDASES; and HEXOSYLTRANSFERASES.
Infections by bacteria, general or unspecified.
Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method.
Tests that are dependent on the clumping of cells, microorganisms, or particles when mixed with specific antiserum. (From Stedman, 26th ed)
The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065)
The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
Infections with bacteria of the family NEISSERIACEAE.
Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.

Ketolide treatment of Haemophilus influenzae experimental pneumonia. (1/1245)

The MICs of HMR 3004 and HMR 3647 at which 90% of beta-lactamase-producing Haemophilus influenzae isolates were inhibited were 4 and 2 micrograms/ml, respectively. Both HMR 3004 and HMR 3647 were active against beta-lactamase-producing H. influenzae in a murine model of experimental pneumonia. As assessed by pulmonary clearance of H. influenzae, HMR 3004 was more effective (P < 0.05) than was azithromycin, ciprofloxacin, clarithromycin, erythromycin A, pristinamycin, or HMR 3647 in this model.  (+info)

Comparative activity of quinupristin/dalfopristin and RPR 106972 and the effect of medium on in-vitro test results. (2/1245)

Quinupristin/dalfopristin and RPR 106972 were active in vitro against a wide range of aerobic Gram-positive organisms including Enterococcus faecium. However, most isolates of Enterococcus faecalis were resistant or of intermediate sensitivity. Against Staphylococcus aureus quinupristin/dalfopristin was more active but for all other species the range of activity of the two drugs was the same or RPR 106972 was more active. RPR 106972 was also more active against the respiratory pathogens Haemophilus influenzae and Moraxella catarrhalis. Quinupristin/dalfopristin MICs for isolates of H. influenzae (1-8 mg/L) clustered around the breakpoint. There were differences in the quality of growth, but little difference in MICs or zone diameters was obtained on three different media: Mueller-Hinton (MHA), Iso-Sensitest (ISA), and Diagnostic Sensitivity Test (DST) agars. The addition of blood to the medium increased MICs 2- to 4-fold, with MHA showing the greatest increase, and reduced zone diameters around quinupristin/dalfopristin discs by 3-4 mm, with the greatest effect on ISA.  (+info)

Candidate bacterial conditions. (3/1245)

This article provides background information on bacterial diseases and discusses those that are candidates for elimination or eradication. Only one disease, neonatal tetanus, is a strong candidate for elimination. Others, including Haemophilus influenzae b infection, leprosy, diphtheria, pertussis, tuberculosis, meningococcal disease, congenital syphilis, trachoma and syphilis are important causes of morbidity and mortality in industrialized and developing countries. For all these diseases, eradication/elimination is not likely because of the characteristics of the disease and limitations in the interventions.  (+info)

Antibiotic strategies for developing countries: experience with acute respiratory tract infections in Pakistan. (4/1245)

The Pakistan program for control of acute respiratory tract infections (ARIs) adopted the standard ARI-case-management strategy of the World Health Organization and recommended co-trimoxazole for the management of nonsevere pneumonia. Reports in that country of high in vitro antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae to co-trimoxazole prompted the program to reevaluate its treatment policy. Two community-based studies during 1991-1993 showed in vivo efficacy of co-trimoxazole in 92% and 91% of children with nonsevere pneumonia. A third double-blind trial showed co-trimoxazole and oral amoxicillin to be equally effective in vivo in cases of nonsevere pneumonia, despite high in vitro resistance. Country-wide surveillance from 1991 to 1994 revealed 78.3%-79.9% in vitro resistance to co-trimoxazole among S. pneumoniae isolates and 59.5%-61.0% among H. influenzae isolates. Co-trimoxazole is still recommended by the Pakistan ARI control program. The fact that amoxicillin is three times more expensive and must be administered more frequently is a big impediment to recommending it as a first-line drug for nonsevere pneumonia.  (+info)

A case-control study of risk factors for Haemophilus influenzae type B disease in Navajo children. (5/1245)

To understand the potential risk factors and protective factors for invasive Haemophilus influenzae type b (Hib) disease, we conducted a case-control study among Navajo children less than two years of age resident on the Navajo Nation. We analyzed household interview data for 60 cases that occurred between August 1988 and February 1991, and for 116 controls matched by age, gender, and geographic location. The Hib vaccine recipients were excluded from the analyses. Conditional logistic regression models were fit to examine many variables relating to social and environmental conditions. Risk factors determined to be important were never breast fed (odds ratio [OR] = 3.55, 95% confidence interval [CI] = 1.52, 8.26), shared care with more than one child less than two years of age (OR = 2.32, 95% CI = 0.91, 5.96); wood heating (OR = 2.14, 95% CI = 0.91, 5.05); rodents in the home (OR = 8.18, 95% CI = 0.83, 80.7); and any livestock near the home (OR = 2.18, 95% CI = 0.94, 5.04).  (+info)

Efficacy of Haemophilus influenzae type b conjugate vaccines and persistence of disease in disadvantaged populations. The Haemophilus Influenzae Study Group. (6/1245)

OBJECTIVES: The purpose of this study was to evaluate the effectiveness of Haemophilus influenzae type b (Hib) conjugate vaccines among children aged 2 to 18 months and to determine risk factors for invasive Hib disease during a period of declining incidence (1991-1994). METHODS: A prospective population-based case-control study was conducted in a multistate US population of 15.5 million. A laboratory-based active surveillance system was used for case detection. RESULTS: In a multivariate analysis, having a single-parent mother (odds ratio [OR] = 4.3, 95% confidence interval [CI] = 1.2, 14.8) and household crowding (OR = 3.5, 95% CI = 1.03, 11.7) were risk factors for Hib disease independent of vaccination status. After adjustment for these risk factors, the protective efficacy of 2 or more Hib vaccine doses was 86% (95% CI = 16%, 98%). Among undervaccinated subjects, living with a smoker (P = .02) and several indicators of lower socioeconomic status were risk factors for Hib disease. CONCLUSIONS: Hib disease still occurs at low levels in the United States, predominantly in socioeconomically disadvantaged populations. Low immunization coverage may facilitate continuing transmission of Hib. Special efforts to achieve complete and timely immunization in disadvantaged populations are needed.  (+info)

Development of an oligonucleotide-specific capture plate hybridization assay for detection of Haemophilus parasuis. (7/1245)

An oligonucleotide-specific capture plate hybridization assay has been developed to rapidly, specifically, and sensitively detect Haemophilus parasuis from nasal swabs. Several in vitro studies have been performed to determine the sensitivity and specificity of the test, and in vivo studies have validated this technique in pigs. Results suggest that the assay detects <100 colony-forming units/ml in a pure culture and gives a positive result when H. parasuis is present in a ratio of 1:10(3)-10(4) in a mixed culture, and the probe does not hybridize with other related species found in the upper respiratory tract. This assay is more sensitive than culture for detection of the microorganism from nasal swabs and lesions.  (+info)

Pulsed-field gel electrophoresis used to investigate genetic diversity of Haemophilus influenzae type b isolates in Australia shows differences between Aboriginal and non-Aboriginal isolates. (8/1245)

We used pulsed-field gel electrophoresis to study the epidemiology and population structure of Haemophilus influenzae type b. DNAs from 187 isolates recovered between 1985 and 1993 from Aboriginal children (n = 76), non-Aboriginal children (n = 106), and non-Aboriginal adults (n = 5) in urban and rural regions across Australia were digested with the SmaI restriction endonuclease. Patterns of 13 to 17 well-resolved fragments (size range, approximately 8 to 500 kb) defining 67 restriction fragment length polymorphism (RFLP) types were found. Two types predominated. One type (n = 37) accounted for 35 (46%) of the isolates from Aboriginals and 2 (2%) of the isolates from non-Aboriginals, and the other type (n = 41) accounted for 2 (3%) of the isolates from Aboriginals and 39 (35%) of the isolates from non-Aboriginals. Clustering revealed seven groups at a genetic distance of approximately 50% similarity in a tree-like dendrogram. They included two highly divergent groups representing 50 (66%) isolates from Aboriginals and 6 (5%) isolates from non-Aboriginals and another genetically distinct group representing 7 (9%) isolates from Aboriginals and 81 (73%) isolates from non-Aboriginals. The results showed a heterogeneous clonal population structure, with the isolates of two types accounting for 42% of the sample. There was no association between RFLP type and the diagnosis of meningitis or epiglottitis, age, sex, date of collection, or geographic location, but there was a strong association between the origin of isolates from Aboriginal children and RFLP type F2a and the origin of isolates from non-Aboriginal children and RFLP type A8b. The methodology discriminated well among the isolates (D = 0.91) and will be useful for the monitoring of postvaccine isolates of H. influenzae type b.  (+info)

Haemophilus infections are caused by bacteria named Haemophilus influenzae. Despite its name, this bacterium does not cause the flu, which is caused by a virus. There are several different strains of Haemophilus influenzae, and some are more likely to cause severe illness than others.

Haemophilus infections can affect people of any age, but they are most common in children under 5 years old. The bacteria can cause a range of infections, from mild ear infections to serious conditions such as meningitis (inflammation of the membranes surrounding the brain and spinal cord) and pneumonia (infection of the lungs).

The bacterium is spread through respiratory droplets when an infected person coughs or sneezes. It can also be spread by touching contaminated surfaces and then touching the mouth, nose, or eyes.

Prevention measures include good hygiene practices such as handwashing, covering the mouth and nose when coughing or sneezing, and avoiding close contact with people who are sick. Vaccination is also available to protect against Haemophilus influenzae type b (Hib) infections, which are the most severe and common form of Haemophilus infection.

Haemophilus is a genus of Gram-negative, facultatively anaerobic bacteria that are commonly found as part of the normal microbiota of the human respiratory tract. However, some species can cause infections in humans, particularly in individuals with weakened immune systems or underlying medical conditions.

The most well-known species is Haemophilus influenzae, which was originally identified as a cause of influenza (hence the name), but it is now known that not all strains of H. influenzae cause this disease. In fact, the majority of H. influenzae infections are caused by strains that produce a polysaccharide capsule, which makes them more virulent and able to evade the host's immune system.

Haemophilus influenzae type b (Hib) was once a major cause of serious bacterial infections in children, including meningitis, pneumonia, and epiglottitis. However, since the introduction of vaccines against Hib in the 1980s, the incidence of these infections has decreased dramatically.

Other Haemophilus species that can cause human infections include Haemophilus parainfluenzae, Haemophilus ducreyi (which causes chancroid), and Haemophilus aphrophilus (which can cause endocarditis).

Haemophilus influenzae is a gram-negative, coccobacillary bacterium that can cause a variety of infectious diseases in humans. It is part of the normal respiratory flora but can become pathogenic under certain circumstances. The bacteria are named after their initial discovery in 1892 by Richard Pfeiffer during an influenza pandemic, although they are not the causative agent of influenza.

There are six main serotypes (a-f) based on the polysaccharide capsule surrounding the bacterium, with type b (Hib) being the most virulent and invasive. Hib can cause severe invasive diseases such as meningitis, pneumonia, epiglottitis, and sepsis, particularly in children under 5 years of age. The introduction of the Hib conjugate vaccine has significantly reduced the incidence of these invasive diseases.

Non-typeable Haemophilus influenzae (NTHi) strains lack a capsule and are responsible for non-invasive respiratory tract infections, such as otitis media, sinusitis, and exacerbations of chronic obstructive pulmonary disease (COPD). NTHi can also cause invasive diseases but at lower frequency compared to Hib.

Proper diagnosis and antibiotic susceptibility testing are crucial for effective treatment, as Haemophilus influenzae strains may display resistance to certain antibiotics.

Haemophilus ducreyi is a gram-negative, oxidase-negative, facultatively anaerobic coccobacillus that is the causative agent of chancroid, a sexually transmitted genital ulcer disease. It requires factors X and V for growth, which makes it fastidious and difficult to culture. The organism primarily infects the epithelial cells of the skin and mucous membranes, causing painful, necrotic ulcers with ragged borders and suppurative inguinal lymphadenopathy. Chancroid is a significant co-factor in the transmission of HIV. Infections caused by H. ducreyi are more common in tropical and developing regions, where it remains an important public health concern.

Haemophilus vaccines are vaccines that are designed to protect against Haemophilus influenzae type b (Hib), a bacterium that can cause serious infections such as meningitis, pneumonia, and epiglottitis. There are two main types of Hib vaccines:

1. Polysaccharide vaccine: This type of vaccine is made from the sugar coating (polysaccharide) of the bacterial cells. It is not effective in children under 2 years of age because their immune systems are not yet mature enough to respond effectively to this type of vaccine.
2. Conjugate vaccine: This type of vaccine combines the polysaccharide with a protein carrier, which helps to stimulate a stronger and more sustained immune response. It is effective in infants as young as 6 weeks old.

Hib vaccines are usually given as part of routine childhood immunizations starting at 2 months of age. They are administered through an injection into the muscle. The vaccine is safe and effective, with few side effects. Vaccination against Hib has led to a significant reduction in the incidence of Hib infections worldwide.

Haemophilus meningitis is a specific type of bacterial meningitis caused by the Haemophilus influenzae type b (Hib) bacteria. Meningitis is an inflammation of the membranes covering the brain and spinal cord, known as the meninges. Before the introduction of the Hib vaccine, Haemophilus influenzae type b was the leading cause of bacterial meningitis in children under 5 years old. However, since the widespread use of the Hib vaccine, the incidence of Haemophilus meningitis has significantly decreased.

Haemophilus influenzae type b bacteria can also cause other serious infections such as pneumonia, epiglottitis (inflammation of the tissue located at the base of the tongue that can obstruct the windpipe), and bacteremia (bloodstream infection). The Hib vaccine has been very effective in preventing these infections as well.

Symptoms of Haemophilus meningitis may include fever, headache, stiff neck, nausea, vomiting, confusion, and sensitivity to light. In severe cases, it can lead to seizures, coma, or even death. If you suspect someone has meningitis, seek immediate medical attention. Haemophilus meningitis is treated with antibiotics, and early treatment is crucial for a better prognosis.

Haemophilus influenzae type b (Hib) is a bacterial subtype that can cause serious infections, particularly in children under 5 years of age. Although its name may be confusing, Hib is not the cause of influenza (the flu). It is defined medically as a gram-negative, coccobacillary bacterium that is a member of the family Pasteurellaceae.

Hib is responsible for several severe and potentially life-threatening infections such as meningitis (inflammation of the membranes surrounding the brain and spinal cord), epiglottitis (swelling of the tissue located at the base of the tongue that can block the windpipe), pneumonia, and bacteremia (bloodstream infection).

Before the introduction of the Hib vaccine in the 1980s and 1990s, Haemophilus influenzae type b was a leading cause of bacterial meningitis in children under 5 years old. Since then, the incidence of invasive Hib disease has decreased dramatically in vaccinated populations.

Haemophilus parasuis is a gram-negative, rod-shaped bacterium that commonly colonizes the upper respiratory tract of pigs. It is a member of the Pasteurellaceae family and can cause a variety of clinical diseases in swine, including Glässer's disease, which is characterized by fibrinous polyserositis, arthritis, and meningitis. The bacterium requires factors V (properdin) and X (Stuart-Prower factor) for growth, which are known as X and V factors, respectively. These requirements make it fastidious and challenging to isolate and culture in the laboratory.

The pathogenicity of H. parasuis varies among strains, with some being more virulent than others. The bacterium can evade the host's immune system by changing its surface antigens, making vaccination difficult. In addition to Glässer's disease, H. parasuis can also cause pneumonia, otitis media, and septicemia in pigs. Control measures include biosecurity, vaccination, and antibiotic treatment of clinically affected animals.

Chancroid is a sexually transmitted infection caused by the bacterium Haemophilus ducreyi. It is characterized by the presence of painful, ulcerating lesions on the genitals. The infection is more common in men than women and is often found in areas with poor sanitation and hygiene. Chancroid is a major cause of genital ulcers in many parts of the world, but it is relatively rare in developed countries.

The primary symptom of chancroid is the development of one or more painful, soft, and easily bleeding ulcers on the genitals within a few days to two weeks after exposure. The ulcers may be accompanied by swelling of the lymph nodes in the groin. In some cases, the ulcers may become covered with a gray or yellowish-white exudate.

Chancroid is diagnosed through the examination of a sample taken from the ulcer. The sample is examined under a microscope for the presence of H. ducreyi bacteria. If the bacteria are not visible, a culture can be grown to confirm the diagnosis.

Treatment for chancroid typically involves the use of antibiotics such as azithromycin or ceftriaxone. It is important to receive treatment promptly to prevent the spread of the infection and to avoid complications such as scarring, difficulty urinating, and infertility.

Prevention measures for chancroid include practicing safe sex, limiting the number of sexual partners, and getting regular STI screenings. If you suspect that you may have chancroid or any other STI, it is important to seek medical attention promptly.

Haemophilus parainfluenzae is a gram-negative, facultatively anaerobic, and non-motile bacterium that frequently colonizes the upper respiratory tract of humans. It is part of the Haemophilus genus in the Pasteurellaceae family. This organism can cause opportunistic infections in various parts of the body, including the respiratory system, bloodstream, and heart valves (endocarditis). However, it is less virulent compared to other Haemophilus species like H. influenzae type b (Hib), which causes more severe invasive diseases.

The medical definition of Haemophilus parainfluenzae includes its taxonomic classification and the characteristics of its growth and potential pathogenicity:

Kingdom: Bacteria
Phylum: Proteobacteria
Class: Gammaproteobacteria
Order: Pasteurellales
Family: Pasteurellaceae
Genus: Haemophilus
Species: parainfluenzae

It is important to note that while H. parainfluenzae can cause infections, it is also commonly found as a commensal organism in the human body. The clinical significance of its presence should be evaluated based on the patient's symptoms and overall health condition.

Haemophilus somnus (also known as Histophilus somni) is not typically defined in a medical dictionary, but it is a gram-negative bacterium that can cause various diseases in animals, particularly in cattle. It is part of the Haemophilus genus and Pasteurellaceae family.

H. somnus can lead to respiratory illnesses, reproductive disorders (such as infertility, abortions, and stillbirths), and systemic infections like sepsis or joint inflammation (arthritis). The bacterium is often found in the upper respiratory tract of healthy cattle, but it can become pathogenic under stressful conditions or when the animal's immune system is weakened.

While Haemophilus somnus primarily affects animals and not humans, there have been rare cases where people working closely with infected animals (such as veterinarians, farmers, or slaughterhouse workers) may develop infections due to exposure. However, this is uncommon, and H. somnus does not typically pose a significant risk to human health.

Ampicillin is a penicillin-type antibiotic used to treat a wide range of bacterial infections. It works by interfering with the ability of bacteria to form cell walls, which are essential for their survival. This causes the bacterial cells to become unstable and eventually die.

The medical definition of Ampicillin is:

"A semi-synthetic penicillin antibiotic, derived from the Penicillium mold. It is used to treat a variety of infections caused by susceptible gram-positive and gram-negative bacteria. Ampicillin is effective against both aerobic and anaerobic organisms. It is commonly used to treat respiratory tract infections, urinary tract infections, meningitis, and endocarditis."

It's important to note that Ampicillin is not effective against infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or other bacteria that have developed resistance to penicillins. Additionally, overuse of antibiotics like Ampicillin can lead to the development of antibiotic resistance, which is a significant public health concern.

Otitis media is an inflammation or infection of the middle ear. It can occur as a result of a cold, respiratory infection, or allergy that causes fluid buildup behind the eardrum. The buildup of fluid can lead to infection and irritation of the middle ear, causing symptoms such as ear pain, hearing loss, and difficulty balancing. There are two types of otitis media: acute otitis media (AOM), which is a short-term infection that can cause fever and severe ear pain, and otitis media with effusion (OME), which is fluid buildup in the middle ear without symptoms of infection. In some cases, otitis media may require medical treatment, including antibiotics or the placement of ear tubes to drain the fluid and relieve pressure on the eardrum.

## I am not aware of a medical definition for the term "chinchilla."

A chinchilla is actually a type of rodent that is native to South America. They have thick, soft fur and are often kept as exotic pets or used in laboratory research. If you're looking for information about chinchillas in a medical context, such as their use in research or any potential health concerns related to keeping them as pets, I would be happy to help you try to find more information on those topics.

Bacterial outer membrane proteins (OMPs) are a type of protein found in the outer membrane of gram-negative bacteria. The outer membrane is a unique characteristic of gram-negative bacteria, and it serves as a barrier that helps protect the bacterium from hostile environments. OMPs play a crucial role in maintaining the structural integrity and selective permeability of the outer membrane. They are involved in various functions such as nutrient uptake, transport, adhesion, and virulence factor secretion.

OMPs are typically composed of beta-barrel structures that span the bacterial outer membrane. These proteins can be classified into several groups based on their size, function, and structure. Some of the well-known OMP families include porins, autotransporters, and two-partner secretion systems.

Porins are the most abundant type of OMPs and form water-filled channels that allow the passive diffusion of small molecules, ions, and nutrients across the outer membrane. Autotransporters are a diverse group of OMPs that play a role in bacterial pathogenesis by secreting virulence factors or acting as adhesins. Two-partner secretion systems involve the cooperation between two proteins to transport effector molecules across the outer membrane.

Understanding the structure and function of bacterial OMPs is essential for developing new antibiotics and therapies that target gram-negative bacteria, which are often resistant to conventional treatments.

Ampicillin resistance is a type of antibiotic resistance where bacteria have the ability to grow in the presence of ampicillin, a beta-lactam antibiotic used to treat various infections. This resistance occurs due to the production of enzymes called beta-lactamases that can break down the ampicillin molecule, rendering it ineffective. Additionally, some bacteria may have mutations that result in changes to their cell wall structure, making them impervious to the effects of ampicillin. Ampicillin resistance is a significant public health concern as it limits treatment options for infections caused by these resistant bacteria and can lead to increased morbidity and mortality.

Bacterial capsules are slimy, gel-like layers that surround many types of bacteria. They are made up of polysaccharides, proteins, or lipopolysaccharides and are synthesized by the bacterial cell. These capsules play a crucial role in the virulence and pathogenicity of bacteria as they help the bacteria to evade the host's immune system and promote their survival and colonization within the host. The presence of a capsule can also contribute to the bacteria's resistance to desiccation, phagocytosis, and antibiotics.

The chemical composition and structure of bacterial capsules vary among different species of bacteria, which is one factor that contributes to their serological specificity and allows for their identification and classification using methods such as the Quellung reaction or immunofluorescence microscopy.

According to the Merriam-Webster Medical Dictionary, 'actinobacillus' is defined as:

"A genus of gram-negative, nonmotile, facultatively anaerobic rods (family Pasteurellaceae) that are parasites or commensals in animals and occasionally cause disease in humans. Some species produce a polysaccharide capsule."

In simpler terms, Actinobacillus is a type of bacteria that can be found in animals, including sometimes as normal flora in their mouths and throats. These bacteria can sometimes infect humans, usually through close contact with animals or through the consumption of contaminated food or water. Some species of Actinobacillus can produce a polysaccharide capsule, which can make them more resistant to the body's immune defenses and more difficult to treat with antibiotics.

It is worth noting that while some species of Actinobacillus can cause disease in humans, they are generally not considered major human pathogens. However, they can cause a variety of clinical syndromes, including respiratory tract infections, wound infections, and bacteremia (bloodstream infections). Treatment typically involves the use of antibiotics that are active against gram-negative bacteria, such as amoxicillin/clavulanate or fluoroquinolones.

Bacterial polysaccharides are complex carbohydrates that consist of long chains of sugar molecules (monosaccharides) linked together by glycosidic bonds. They are produced and used by bacteria for various purposes such as:

1. Structural components: Bacterial polysaccharides, such as peptidoglycan and lipopolysaccharide (LPS), play a crucial role in maintaining the structural integrity of bacterial cells. Peptidoglycan is a major component of the bacterial cell wall, while LPS forms the outer layer of the outer membrane in gram-negative bacteria.
2. Nutrient storage: Some bacteria synthesize and store polysaccharides as an energy reserve, similar to how plants store starch. These polysaccharides can be broken down and utilized by the bacterium when needed.
3. Virulence factors: Bacterial polysaccharides can also function as virulence factors, contributing to the pathogenesis of bacterial infections. For example, certain bacteria produce capsular polysaccharides (CPS) that surround and protect the bacterial cells from host immune defenses, allowing them to evade phagocytosis and persist within the host.
4. Adhesins: Some polysaccharides act as adhesins, facilitating the attachment of bacteria to surfaces or host cells. This is important for biofilm formation, which helps bacteria resist environmental stresses and antibiotic treatments.
5. Antigenic properties: Bacterial polysaccharides can be highly antigenic, eliciting an immune response in the host. The antigenicity of these molecules can vary between different bacterial species or even strains within a species, making them useful as targets for vaccines and diagnostic tests.

In summary, bacterial polysaccharides are complex carbohydrates that serve various functions in bacteria, including structural support, nutrient storage, virulence factor production, adhesion, and antigenicity.

Bacterial antibodies are a type of antibodies produced by the immune system in response to an infection caused by bacteria. These antibodies are proteins that recognize and bind to specific antigens on the surface of the bacterial cells, marking them for destruction by other immune cells. Bacterial antibodies can be classified into several types based on their structure and function, including IgG, IgM, IgA, and IgE. They play a crucial role in the body's defense against bacterial infections and provide immunity to future infections with the same bacteria.

Microbial sensitivity tests, also known as antibiotic susceptibility tests (ASTs) or bacterial susceptibility tests, are laboratory procedures used to determine the effectiveness of various antimicrobial agents against specific microorganisms isolated from a patient's infection. These tests help healthcare providers identify which antibiotics will be most effective in treating an infection and which ones should be avoided due to resistance. The results of these tests can guide appropriate antibiotic therapy, minimize the potential for antibiotic resistance, improve clinical outcomes, and reduce unnecessary side effects or toxicity from ineffective antimicrobials.

There are several methods for performing microbial sensitivity tests, including:

1. Disk diffusion method (Kirby-Bauer test): A standardized paper disk containing a predetermined amount of an antibiotic is placed on an agar plate that has been inoculated with the isolated microorganism. After incubation, the zone of inhibition around the disk is measured to determine the susceptibility or resistance of the organism to that particular antibiotic.
2. Broth dilution method: A series of tubes or wells containing decreasing concentrations of an antimicrobial agent are inoculated with a standardized microbial suspension. After incubation, the minimum inhibitory concentration (MIC) is determined by observing the lowest concentration of the antibiotic that prevents visible growth of the organism.
3. Automated systems: These use sophisticated technology to perform both disk diffusion and broth dilution methods automatically, providing rapid and accurate results for a wide range of microorganisms and antimicrobial agents.

The interpretation of microbial sensitivity test results should be done cautiously, considering factors such as the site of infection, pharmacokinetics and pharmacodynamics of the antibiotic, potential toxicity, and local resistance patterns. Regular monitoring of susceptibility patterns and ongoing antimicrobial stewardship programs are essential to ensure optimal use of these tests and to minimize the development of antibiotic resistance.

Bacterial DNA refers to the genetic material found in bacteria. It is composed of a double-stranded helix containing four nucleotide bases - adenine (A), thymine (T), guanine (G), and cytosine (C) - that are linked together by phosphodiester bonds. The sequence of these bases in the DNA molecule carries the genetic information necessary for the growth, development, and reproduction of bacteria.

Bacterial DNA is circular in most bacterial species, although some have linear chromosomes. In addition to the main chromosome, many bacteria also contain small circular pieces of DNA called plasmids that can carry additional genes and provide resistance to antibiotics or other environmental stressors.

Unlike eukaryotic cells, which have their DNA enclosed within a nucleus, bacterial DNA is present in the cytoplasm of the cell, where it is in direct contact with the cell's metabolic machinery. This allows for rapid gene expression and regulation in response to changing environmental conditions.

Conjugate vaccines are a type of vaccine that combines a part of a bacterium with a protein or other substance to boost the body's immune response to the bacteria. The bacterial component is usually a polysaccharide, which is a long chain of sugars that makes up part of the bacterial cell wall.

By itself, a polysaccharide is not very immunogenic, meaning it does not stimulate a strong immune response. However, when it is conjugated or linked to a protein or other carrier molecule, it becomes much more immunogenic and can elicit a stronger and longer-lasting immune response.

Conjugate vaccines are particularly effective in protecting against bacterial infections that affect young children, such as Haemophilus influenzae type b (Hib) and pneumococcal disease. These vaccines have been instrumental in reducing the incidence of these diseases and their associated complications, such as meningitis and pneumonia.

Overall, conjugate vaccines work by mimicking a natural infection and stimulating the immune system to produce antibodies that can protect against future infections with the same bacterium. By combining a weakly immunogenic polysaccharide with a protein carrier, these vaccines can elicit a stronger and more effective immune response, providing long-lasting protection against bacterial infections.

Haemophilus paragallinarum is a gram-negative, rod-shaped bacterium that is the primary cause of infectious coryza, an upper respiratory disease in birds, particularly chickens. The bacteria colonize and infect the mucosal surfaces of the upper respiratory tract, leading to clinical signs such as sneezing, coughing, nasal discharge, and difficulty breathing. In severe cases, it can result in significant economic losses for poultry farmers due to decreased egg production, poor feed conversion, and increased mortality rates. It is transmitted through direct contact with infected birds or contaminated surfaces, making biosecurity measures essential to control its spread.

Streptococcus pneumoniae, also known as the pneumococcus, is a gram-positive, alpha-hemolytic bacterium frequently found in the upper respiratory tract of healthy individuals. It is a leading cause of community-acquired pneumonia and can also cause other infectious diseases such as otitis media (ear infection), sinusitis, meningitis, and bacteremia (bloodstream infection). The bacteria are encapsulated, and there are over 90 serotypes based on variations in the capsular polysaccharide. Some serotypes are more virulent or invasive than others, and the polysaccharide composition is crucial for vaccine development. S. pneumoniae infection can be treated with antibiotics, but the emergence of drug-resistant strains has become a significant global health concern.

Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.

Pleuropneumonia is a medical condition characterized by inflammation that affects both the lung tissue (pneumonia) and the pleural space (pleurisy) surrounding the lungs. It is often caused by bacterial infections, such as Streptococcus pneumoniae or Haemophilus influenzae, that spread from the lungs to the pleural space.

The inflammation can cause symptoms such as chest pain, cough, fever, and difficulty breathing. In severe cases, it may lead to complications such as pleural effusion (accumulation of fluid in the pleural space), lung abscesses, or empyema (pus in the pleural space).

Pleuropneumonia can be diagnosed through physical examination, medical history, imaging studies such as chest X-rays or CT scans, and laboratory tests such as blood cultures or analysis of sputum or pleural fluid. Treatment typically involves antibiotics to eliminate the infection, along with supportive care such as pain management, hydration, and respiratory support if necessary.

Bacterial proteins are a type of protein that are produced by bacteria as part of their structural or functional components. These proteins can be involved in various cellular processes, such as metabolism, DNA replication, transcription, and translation. They can also play a role in bacterial pathogenesis, helping the bacteria to evade the host's immune system, acquire nutrients, and multiply within the host.

Bacterial proteins can be classified into different categories based on their function, such as:

1. Enzymes: Proteins that catalyze chemical reactions in the bacterial cell.
2. Structural proteins: Proteins that provide structural support and maintain the shape of the bacterial cell.
3. Signaling proteins: Proteins that help bacteria to communicate with each other and coordinate their behavior.
4. Transport proteins: Proteins that facilitate the movement of molecules across the bacterial cell membrane.
5. Toxins: Proteins that are produced by pathogenic bacteria to damage host cells and promote infection.
6. Surface proteins: Proteins that are located on the surface of the bacterial cell and interact with the environment or host cells.

Understanding the structure and function of bacterial proteins is important for developing new antibiotics, vaccines, and other therapeutic strategies to combat bacterial infections.

Bacterial transformation is a natural process by which exogenous DNA is taken up and incorporated into the genome of a bacterial cell. This process was first discovered in 1928 by Frederick Griffith, who observed that dead virulent bacteria could transfer genetic material to live avirulent bacteria, thereby conferring new properties such as virulence to the recipient cells.

The uptake of DNA by bacterial cells typically occurs through a process called "competence," which can be either naturally induced under certain environmental conditions or artificially induced in the laboratory using various methods. Once inside the cell, the exogenous DNA may undergo recombination with the host genome, resulting in the acquisition of new genes or the alteration of existing ones.

Bacterial transformation has important implications for both basic research and biotechnology. It is a powerful tool for studying gene function and for engineering bacteria with novel properties, such as the ability to produce valuable proteins or degrade environmental pollutants. However, it also poses potential risks in the context of genetic engineering and biocontainment, as transformed bacteria may be able to transfer their newly acquired genes to other organisms in the environment.

A bacterial gene is a segment of DNA (or RNA in some viruses) that contains the genetic information necessary for the synthesis of a functional bacterial protein or RNA molecule. These genes are responsible for encoding various characteristics and functions of bacteria such as metabolism, reproduction, and resistance to antibiotics. They can be transmitted between bacteria through horizontal gene transfer mechanisms like conjugation, transformation, and transduction. Bacterial genes are often organized into operons, which are clusters of genes that are transcribed together as a single mRNA molecule.

It's important to note that the term "bacterial gene" is used to describe genetic elements found in bacteria, but not all genetic elements in bacteria are considered genes. For example, some DNA sequences may not encode functional products and are therefore not considered genes. Additionally, some bacterial genes may be plasmid-borne or phage-borne, rather than being located on the bacterial chromosome.

The middle ear is the middle of the three parts of the ear, located between the outer ear and inner ear. It contains three small bones called ossicles (the malleus, incus, and stapes) that transmit and amplify sound vibrations from the eardrum to the inner ear. The middle ear also contains the Eustachian tube, which helps regulate air pressure in the middle ear and protects against infection by allowing fluid to drain from the middle ear into the back of the throat.

Respiratory tract infections (RTIs) are infections that affect the respiratory system, which includes the nose, throat (pharynx), voice box (larynx), windpipe (trachea), bronchi, and lungs. These infections can be caused by viruses, bacteria, or, less commonly, fungi.

RTIs are classified into two categories based on their location: upper respiratory tract infections (URTIs) and lower respiratory tract infections (LRTIs). URTIs include infections of the nose, sinuses, throat, and larynx, such as the common cold, flu, laryngitis, and sinusitis. LRTIs involve the lower airways, including the bronchi and lungs, and can be more severe. Examples of LRTIs are pneumonia, bronchitis, and bronchiolitis.

Symptoms of RTIs depend on the location and cause of the infection but may include cough, congestion, runny nose, sore throat, difficulty breathing, wheezing, fever, fatigue, and chest pain. Treatment for RTIs varies depending on the severity and underlying cause of the infection. For viral infections, treatment typically involves supportive care to manage symptoms, while antibiotics may be prescribed for bacterial infections.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Combined vaccines are defined in medical terms as vaccines that contain two or more antigens from different diseases, which are given to provide protection against multiple diseases at the same time. This approach reduces the number of injections required and simplifies the immunization schedule, especially during early childhood. Examples of combined vaccines include:

1. DTaP-Hib-IPV (e.g., Pentacel): A vaccine that combines diphtheria, tetanus, pertussis (whooping cough), Haemophilus influenzae type b (Hib) disease, and poliovirus components in one injection to protect against these five diseases.
2. MMRV (e.g., ProQuad): A vaccine that combines measles, mumps, rubella, and varicella (chickenpox) antigens in a single injection to provide immunity against all four diseases.
3. HepA-HepB (e.g., Twinrix): A vaccine that combines hepatitis A and hepatitis B antigens in one injection, providing protection against both types of hepatitis.
4. MenACWY-TT (e.g., MenQuadfi): A vaccine that combines four serogroups of meningococcal bacteria (A, C, W, Y) with tetanus toxoid as a carrier protein in one injection for the prevention of invasive meningococcal disease caused by these serogroups.
5. PCV13-PPSV23 (e.g., Vaxneuvance): A vaccine that combines 13 pneumococcal serotypes with PPSV23, providing protection against a broader range of pneumococcal diseases in adults aged 18 years and older.

Combined vaccines have been thoroughly tested for safety and efficacy to ensure they provide a strong immune response and an acceptable safety profile. They are essential tools in preventing various infectious diseases and improving overall public health.

The Amoxicillin-Potassium Clavulanate Combination is an antibiotic medication used to treat various infections caused by bacteria. This combination therapy combines the antibiotic amoxicillin with potassium clavulanate, which is a beta-lactamase inhibitor. The addition of potassium clavulanate helps protect amoxicillin from being broken down by certain types of bacteria that produce beta-lactamases, thus increasing the effectiveness of the antibiotic against a broader range of bacterial infections.

Amoxicillin is a type of penicillin antibiotic that works by inhibiting the synthesis of the bacterial cell wall, ultimately leading to bacterial death. However, some bacteria have developed enzymes called beta-lactamases, which can break down and inactivate certain antibiotics like amoxicillin. Potassium clavulanate is added to the combination to inhibit these beta-lactamase enzymes, allowing amoxicillin to maintain its effectiveness against a wider range of bacteria.

This combination medication is used to treat various infections, including skin and soft tissue infections, respiratory tract infections, urinary tract infections, and dental infections. It's essential to follow the prescribed dosage and duration as directed by a healthcare professional to ensure effective treatment and prevent antibiotic resistance.

Common brand names for this combination include Augmentin and Amoxiclav.

Beta-lactamases are enzymes produced by certain bacteria that can break down and inactivate beta-lactam antibiotics, such as penicillins, cephalosporins, and carbapenems. This enzymatic activity makes the bacteria resistant to these antibiotics, limiting their effectiveness in treating infections caused by these organisms.

Beta-lactamases work by hydrolyzing the beta-lactam ring, a structural component of these antibiotics that is essential for their antimicrobial activity. By breaking down this ring, the enzyme renders the antibiotic ineffective against the bacterium, allowing it to continue growing and potentially causing harm.

There are different classes of beta-lactamases (e.g., Ambler Class A, B, C, and D), each with distinct characteristics and mechanisms for breaking down various beta-lactam antibiotics. The emergence and spread of bacteria producing these enzymes have contributed to the growing problem of antibiotic resistance, making it increasingly challenging to treat infections caused by these organisms.

To overcome this issue, researchers have developed beta-lactamase inhibitors, which are drugs that can bind to and inhibit the activity of these enzymes, thus restoring the effectiveness of certain beta-lactam antibiotics. Examples of such combinations include amoxicillin/clavulanate (Augmentin) and piperacillin/tazobactam (Zosyn).

Pasteurellaceae is a family of Gram-negative, facultatively anaerobic or aerobic, non-spore forming bacteria that are commonly found as normal flora in the upper respiratory tract, gastrointestinal tract, and genitourinary tract of animals and humans. Some members of this family can cause a variety of diseases in animals and humans, including pneumonia, meningitis, septicemia, and localized infections such as abscesses and cellulitis.

Some notable genera within Pasteurellaceae include:

* Pasteurella: includes several species that can cause respiratory tract infections, septicemia, and soft tissue infections in animals and humans. The most common species is Pasteurella multocida, which is a major pathogen in animals and can also cause human infections associated with animal bites or scratches.
* Haemophilus: includes several species that are normal flora of the human respiratory tract and can cause respiratory tract infections, including bronchitis, pneumonia, and meningitis. The most well-known species is Haemophilus influenzae, which can cause severe invasive diseases such as meningitis and sepsis, particularly in young children.
* Mannheimia: includes several species that are normal flora of the upper respiratory tract of ruminants (such as cattle and sheep) and can cause pneumonia and other respiratory tract infections in these animals. The most common species is Mannheimia haemolytica, which is a major pathogen in cattle and can also cause human infections associated with animal contact.
* Actinobacillus: includes several species that are normal flora of the upper respiratory tract and gastrointestinal tract of animals and can cause respiratory tract infections, septicemia, and localized infections in these animals. The most common species is Actinobacillus pleuropneumoniae, which causes a severe form of pneumonia in pigs.

Overall, Pasteurellaceae family members are important pathogens in both veterinary and human medicine, and their infections can range from mild to severe and life-threatening.

Diphtheria toxoid is a modified form of the diphtheria toxin that has been made harmless but still stimulates an immune response. It is used in vaccines to provide immunity against diphtheria, a serious bacterial infection that can cause breathing difficulties, heart failure, and paralysis. The toxoid is typically combined with other components in a vaccine, such as tetanus toxoid and pertussis vaccine, to form a combination vaccine that protects against multiple diseases.

The diphtheria toxoid is made by treating the diphtheria toxin with formaldehyde, which modifies the toxin's structure and makes it nontoxic while still retaining its ability to stimulate an immune response. When the toxoid is introduced into the body through vaccination, the immune system recognizes it as a foreign substance and produces antibodies against it. These antibodies then provide protection against future infections with the diphtheria bacteria.

The diphtheria toxoid vaccine is usually given as part of a routine childhood immunization schedule, starting at 2 months of age. Booster shots are recommended throughout childhood and adolescence, and adults may also need booster shots if they have not received them previously or if their immune status has changed.

Cephalosporins are a class of antibiotics that are derived from the fungus Acremonium, originally isolated from seawater and cow dung. They have a similar chemical structure to penicillin and share a common four-membered beta-lactam ring in their molecular structure.

Cephalosporins work by inhibiting the synthesis of bacterial cell walls, which ultimately leads to bacterial death. They are broad-spectrum antibiotics, meaning they are effective against a wide range of bacteria, including both Gram-positive and Gram-negative organisms.

There are several generations of cephalosporins, each with different spectra of activity and pharmacokinetic properties. The first generation cephalosporins have a narrow spectrum of activity and are primarily used to treat infections caused by susceptible Gram-positive bacteria, such as Staphylococcus aureus and Streptococcus pneumoniae.

Second-generation cephalosporins have an expanded spectrum of activity that includes some Gram-negative organisms, such as Escherichia coli and Haemophilus influenzae. Third-generation cephalosporins have even broader spectra of activity and are effective against many resistant Gram-negative bacteria, such as Pseudomonas aeruginosa and Klebsiella pneumoniae.

Fourth-generation cephalosporins have activity against both Gram-positive and Gram-negative organisms, including some that are resistant to other antibiotics. They are often reserved for the treatment of serious infections caused by multidrug-resistant bacteria.

Cephalosporins are generally well tolerated, but like penicillin, they can cause allergic reactions in some individuals. Cross-reactivity between cephalosporins and penicillin is estimated to occur in 5-10% of patients with a history of penicillin allergy. Other potential adverse effects include gastrointestinal symptoms (such as nausea, vomiting, and diarrhea), neurotoxicity, and nephrotoxicity.

Epiglottitis is a medical condition characterized by inflammation and swelling of the epiglottis, which is a flap of tissue that sits at the base of the tongue and covers the windpipe (trachea) during swallowing to prevent food and liquids from entering the airway. When the epiglottis becomes inflamed and swollen, it can obstruct the flow of air into the lungs, leading to difficulty breathing and other symptoms such as fever, sore throat, and drooling. Epiglottitis is a medical emergency that requires immediate treatment, often with antibiotics and airway management measures such as intubation or tracheostomy.

Chloramphenicol is an antibiotic medication that is used to treat a variety of bacterial infections. It works by inhibiting the ability of bacteria to synthesize proteins, which essential for their growth and survival. This helps to stop the spread of the infection and allows the body's immune system to clear the bacteria from the body.

Chloramphenicol is a broad-spectrum antibiotic, which means that it is effective against many different types of bacteria. It is often used to treat serious infections that have not responded to other antibiotics. However, because of its potential for serious side effects, including bone marrow suppression and gray baby syndrome, chloramphenicol is usually reserved for use in cases where other antibiotics are not effective or are contraindicated.

Chloramphenicol can be given by mouth, injection, or applied directly to the skin in the form of an ointment or cream. It is important to take or use chloramphenicol exactly as directed by a healthcare provider, and to complete the full course of treatment even if symptoms improve before all of the medication has been taken. This helps to ensure that the infection is fully treated and reduces the risk of antibiotic resistance.

Tetanus toxoid is a purified and inactivated form of the tetanus toxin, which is derived from the bacterium Clostridium tetani. It is used as a vaccine to induce active immunity against tetanus, a potentially fatal disease caused by this toxin. The toxoid is produced through a series of chemical treatments that modify the toxic properties of the tetanus toxin while preserving its antigenic qualities. This allows the immune system to recognize and develop protective antibodies against the toxin without causing illness. Tetanus toxoid is often combined with diphtheria and/or pertussis toxoids in vaccines such as DTaP, Tdap, and Td.

The Diphtheria-Tetanus-Pertussis (DTaP) vaccine is a combination immunization that protects against three bacterial diseases: diphtheria, tetanus (lockjaw), and pertussis (whooping cough).

Diphtheria is an upper respiratory infection that can lead to breathing difficulties, heart failure, paralysis, or even death. Tetanus is a bacterial infection that affects the nervous system and causes muscle stiffness and spasms, leading to "lockjaw." Pertussis is a highly contagious respiratory infection characterized by severe coughing fits, which can make it difficult to breathe and may lead to pneumonia, seizures, or brain damage.

The DTaP vaccine contains inactivated toxins (toxoids) from the bacteria that cause these diseases. It is typically given as a series of five shots, with doses administered at 2 months, 4 months, 6 months, 15-18 months, and 4-6 years of age. The vaccine helps the immune system develop protection against the diseases without causing the actual illness.

It is important to note that there are other combination vaccines available that protect against these same diseases, such as DT (diphtheria and tetanus toxoids) and Tdap (tetanus, diphtheria, and acellular pertussis), which contain higher doses of the diphtheria and pertussis components. These vaccines are recommended for different age groups and may be used as booster shots to maintain immunity throughout adulthood.

Penicillin resistance is the ability of certain bacteria to withstand the antibacterial effects of penicillin, a type of antibiotic. This occurs when these bacteria have developed mechanisms that prevent penicillin from binding to and inhibiting the function of their cell wall biosynthesis proteins, particularly the enzyme transpeptidase.

One common mechanism of penicillin resistance is the production of beta-lactamases, enzymes that can hydrolyze and inactivate the beta-lactam ring structure present in penicillin and other related antibiotics. Another mechanism involves alterations in the bacterial cell wall that prevent penicillin from binding to its target proteins.

Penicillin resistance is a significant concern in clinical settings, as it can limit treatment options for bacterial infections and may necessitate the use of more potent or toxic antibiotics. It is important to note that misuse or overuse of antibiotics can contribute to the development and spread of antibiotic-resistant bacteria, including those resistant to penicillin.

Bacterial antigens are substances found on the surface or produced by bacteria that can stimulate an immune response in a host organism. These antigens can be proteins, polysaccharides, teichoic acids, lipopolysaccharides, or other molecules that are recognized as foreign by the host's immune system.

When a bacterial antigen is encountered by the host's immune system, it triggers a series of responses aimed at eliminating the bacteria and preventing infection. The host's immune system recognizes the antigen as foreign through the use of specialized receptors called pattern recognition receptors (PRRs), which are found on various immune cells such as macrophages, dendritic cells, and neutrophils.

Once a bacterial antigen is recognized by the host's immune system, it can stimulate both the innate and adaptive immune responses. The innate immune response involves the activation of inflammatory pathways, the recruitment of immune cells to the site of infection, and the production of antimicrobial peptides.

The adaptive immune response, on the other hand, involves the activation of T cells and B cells, which are specific to the bacterial antigen. These cells can recognize and remember the antigen, allowing for a more rapid and effective response upon subsequent exposures.

Bacterial antigens are important in the development of vaccines, as they can be used to stimulate an immune response without causing disease. By identifying specific bacterial antigens that are associated with virulence or pathogenicity, researchers can develop vaccines that target these antigens and provide protection against infection.

Culture media is a substance that is used to support the growth of microorganisms or cells in an artificial environment, such as a petri dish or test tube. It typically contains nutrients and other factors that are necessary for the growth and survival of the organisms being cultured. There are many different types of culture media, each with its own specific formulation and intended use. Some common examples include blood agar, which is used to culture bacteria; Sabouraud dextrose agar, which is used to culture fungi; and Eagle's minimum essential medium, which is used to culture animal cells.

Blood bactericidal activity refers to the ability of an individual's blood to kill or inhibit the growth of bacteria. This is an important aspect of the body's immune system, as it helps to prevent infection and maintain overall health. The bactericidal activity of blood can be influenced by various factors, including the presence of antibodies, white blood cells (such as neutrophils), and complement proteins.

In medical terms, the term "bactericidal" specifically refers to an agent or substance that is capable of killing bacteria. Therefore, when we talk about blood bactericidal activity, we are referring to the collective ability of various components in the blood to kill or inhibit the growth of bacteria. This is often measured in laboratory tests as a way to assess a person's immune function and their susceptibility to infection.

It's worth noting that not all substances in the blood are bactericidal; some may simply inhibit the growth of bacteria without killing them. These substances are referred to as bacteriostatic. Both bactericidal and bacteriostatic agents play important roles in maintaining the body's defense against infection.

Bacterial adhesion is the initial and crucial step in the process of bacterial colonization, where bacteria attach themselves to a surface or tissue. This process involves specific interactions between bacterial adhesins (proteins, fimbriae, or pili) and host receptors (glycoproteins, glycolipids, or extracellular matrix components). The attachment can be either reversible or irreversible, depending on the strength of interaction. Bacterial adhesion is a significant factor in initiating biofilm formation, which can lead to various infectious diseases and medical device-associated infections.

Microbial drug resistance is a significant medical issue that refers to the ability of microorganisms (such as bacteria, viruses, fungi, or parasites) to withstand or survive exposure to drugs or medications designed to kill them or limit their growth. This phenomenon has become a major global health concern, particularly in the context of bacterial infections, where it is also known as antibiotic resistance.

Drug resistance arises due to genetic changes in microorganisms that enable them to modify or bypass the effects of antimicrobial agents. These genetic alterations can be caused by mutations or the acquisition of resistance genes through horizontal gene transfer. The resistant microbes then replicate and multiply, forming populations that are increasingly difficult to eradicate with conventional treatments.

The consequences of drug-resistant infections include increased morbidity, mortality, healthcare costs, and the potential for widespread outbreaks. Factors contributing to the emergence and spread of microbial drug resistance include the overuse or misuse of antimicrobials, poor infection control practices, and inadequate surveillance systems.

To address this challenge, it is crucial to promote prudent antibiotic use, strengthen infection prevention and control measures, develop new antimicrobial agents, and invest in research to better understand the mechanisms underlying drug resistance.

Bacteria are single-celled microorganisms that are among the earliest known life forms on Earth. They are typically characterized as having a cell wall and no membrane-bound organelles. The majority of bacteria have a prokaryotic organization, meaning they lack a nucleus and other membrane-bound organelles.

Bacteria exist in diverse environments and can be found in every habitat on Earth, including soil, water, and the bodies of plants and animals. Some bacteria are beneficial to their hosts, while others can cause disease. Beneficial bacteria play important roles in processes such as digestion, nitrogen fixation, and biogeochemical cycling.

Bacteria reproduce asexually through binary fission or budding, and some species can also exchange genetic material through conjugation. They have a wide range of metabolic capabilities, with many using organic compounds as their source of energy, while others are capable of photosynthesis or chemosynthesis.

Bacteria are highly adaptable and can evolve rapidly in response to environmental changes. This has led to the development of antibiotic resistance in some species, which poses a significant public health challenge. Understanding the biology and behavior of bacteria is essential for developing strategies to prevent and treat bacterial infections and diseases.

Cefaclor is a type of antibiotic known as a second-generation cephalosporin. It works by interfering with the bacteria's ability to form a cell wall, which is necessary for its survival. Without a functional cell wall, the bacteria eventually die. Cefaclor is effective against a wide range of gram-positive and gram-negative bacteria, making it a broad-spectrum antibiotic.

Cefaclor is used to treat various types of bacterial infections, including respiratory tract infections (such as bronchitis and pneumonia), ear infections, skin infections, and urinary tract infections. It is available in both oral and intravenous forms.

Like all antibiotics, cefaclor should be used only to treat bacterial infections, as it is not effective against viral infections such as the common cold or flu. Overuse of antibiotics can lead to the development of antibiotic-resistant bacteria, which can make future infections more difficult to treat. It is important to take cefaclor exactly as directed by a healthcare professional and to complete the full course of treatment, even if symptoms improve before all of the medication has been taken.

Swine diseases refer to a wide range of infectious and non-infectious conditions that affect pigs. These diseases can be caused by viruses, bacteria, fungi, parasites, or environmental factors. Some common swine diseases include:

1. Porcine Reproductive and Respiratory Syndrome (PRRS): a viral disease that causes reproductive failure in sows and respiratory problems in piglets and grower pigs.
2. Classical Swine Fever (CSF): also known as hog cholera, is a highly contagious viral disease that affects pigs of all ages.
3. Porcine Circovirus Disease (PCVD): a group of diseases caused by porcine circoviruses, including Porcine CircoVirus Associated Disease (PCVAD) and Postweaning Multisystemic Wasting Syndrome (PMWS).
4. Swine Influenza: a respiratory disease caused by type A influenza viruses that can infect pigs and humans.
5. Mycoplasma Hyopneumoniae: a bacterial disease that causes pneumonia in pigs.
6. Actinobacillus Pleuropneumoniae: a bacterial disease that causes severe pneumonia in pigs.
7. Salmonella: a group of bacteria that can cause food poisoning in humans and a variety of diseases in pigs, including septicemia, meningitis, and abortion.
8. Brachyspira Hyodysenteriae: a bacterial disease that causes dysentery in pigs.
9. Erysipelothrix Rhusiopathiae: a bacterial disease that causes erysipelas in pigs.
10. External and internal parasites, such as lice, mites, worms, and flukes, can also cause diseases in swine.

Prevention and control of swine diseases rely on good biosecurity practices, vaccination programs, proper nutrition, and management practices. Regular veterinary check-ups and monitoring are essential to detect and treat diseases early.

The oropharynx is the part of the throat (pharynx) that is located immediately behind the mouth and includes the back one-third of the tongue, the soft palate, the side and back walls of the throat, and the tonsils. It serves as a passageway for both food and air, and is also an important area for the immune system due to the presence of tonsils.

Serotyping is a laboratory technique used to classify microorganisms, such as bacteria and viruses, based on the specific antigens or proteins present on their surface. It involves treating the microorganism with different types of antibodies and observing which ones bind to its surface. Each distinct set of antigens corresponds to a specific serotype, allowing for precise identification and characterization of the microorganism. This technique is particularly useful in epidemiology, vaccine development, and infection control.

Meningitis is a medical condition characterized by the inflammation of the meninges, which are the membranes that cover the brain and spinal cord. This inflammation can be caused by various infectious agents, such as bacteria, viruses, fungi, or parasites, or by non-infectious causes like autoimmune diseases, cancer, or certain medications.

The symptoms of meningitis may include fever, headache, stiff neck, nausea, vomiting, confusion, and sensitivity to light. In severe cases, it can lead to seizures, coma, or even death if not treated promptly and effectively. Bacterial meningitis is usually more severe and requires immediate medical attention, while viral meningitis is often less severe and may resolve on its own without specific treatment.

It's important to note that meningitis can be a serious and life-threatening condition, so if you suspect that you or someone else has symptoms of meningitis, you should seek medical attention immediately.

Bacterial meningitis is a serious infection that causes the membranes (meninges) surrounding the brain and spinal cord to become inflamed. It's caused by various types of bacteria, such as Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type b.

The infection can develop quickly, over a few hours or days, and is considered a medical emergency. Symptoms may include sudden high fever, severe headache, stiff neck, nausea, vomiting, confusion, and sensitivity to light. In some cases, a rash may also be present.

Bacterial meningitis can lead to serious complications such as brain damage, hearing loss, learning disabilities, and even death if not treated promptly with appropriate antibiotics and supportive care. It is important to seek immediate medical attention if you suspect bacterial meningitis. Vaccines are available to prevent certain types of bacterial meningitis.

"Neisseria" is a genus of gram-negative, aerobic bacteria that are commonly found as part of the normal flora in the human body, particularly in the mouth, nose, and genital tract. Some species of Neisseria can cause diseases in humans, the most well-known being Neisseria meningitidis (meningococcus), which can cause meningitis and sepsis, and Neisseria gonorrhoeae (gonococcus), which causes the sexually transmitted infection gonorrhea. These bacteria are named after German physician and bacteriologist Albert Neisser, who first described them in the late 19th century.

A carrier state is a condition in which a person carries and may be able to transmit a genetic disorder or infectious disease, but does not show any symptoms of the disease themselves. This occurs when an individual has a recessive allele for a genetic disorder or is infected with a pathogen, but does not have the necessary combination of genes or other factors required to develop the full-blown disease.

For example, in the case of cystic fibrosis, which is caused by mutations in the CFTR gene, a person who carries one normal allele and one mutated allele for the disease is considered a carrier. They do not have symptoms of cystic fibrosis themselves, but they can pass the mutated allele on to their offspring, who may then develop the disease if they inherit the mutation from both parents.

Similarly, in the case of infectious diseases, a person who is infected with a pathogen but does not show any symptoms may still be able to transmit the infection to others. This is known as being an asymptomatic carrier or a healthy carrier. For example, some people who are infected with hepatitis B virus (HBV) may not develop any symptoms of liver disease, but they can still transmit the virus to others through contact with their blood or other bodily fluids.

It's important to note that in some cases, carriers of certain genetic disorders or infectious diseases may have mild or atypical symptoms that do not meet the full criteria for a diagnosis of the disease. In these cases, they may be considered to have a "reduced penetrance" or "incomplete expression" of the disorder or infection.

Bacterial vaccines are types of vaccines that are created using bacteria or parts of bacteria as the immunogen, which is the substance that triggers an immune response in the body. The purpose of a bacterial vaccine is to stimulate the immune system to develop protection against specific bacterial infections.

There are several types of bacterial vaccines, including:

1. Inactivated or killed whole-cell vaccines: These vaccines contain entire bacteria that have been killed or inactivated through various methods, such as heat or chemicals. The bacteria can no longer cause disease, but they still retain the ability to stimulate an immune response.
2. Subunit, protein, or polysaccharide vaccines: These vaccines use specific components of the bacterium, such as proteins or polysaccharides, that are known to trigger an immune response. By using only these components, the vaccine can avoid using the entire bacterium, which may reduce the risk of adverse reactions.
3. Live attenuated vaccines: These vaccines contain live bacteria that have been weakened or attenuated so that they cannot cause disease but still retain the ability to stimulate an immune response. This type of vaccine can provide long-lasting immunity, but it may not be suitable for people with weakened immune systems.

Bacterial vaccines are essential tools in preventing and controlling bacterial infections, reducing the burden of diseases such as tuberculosis, pneumococcal disease, meningococcal disease, and Haemophilus influenzae type b (Hib) disease. They work by exposing the immune system to a harmless form of the bacteria or its components, which triggers the production of antibodies and memory cells that can recognize and fight off future infections with that same bacterium.

It's important to note that while vaccines are generally safe and effective, they may cause mild side effects such as pain, redness, or swelling at the injection site, fever, or fatigue. Serious side effects are rare but can occur, so it's essential to consult with a healthcare provider before receiving any vaccine.

Cefuroxime is a type of antibiotic known as a cephalosporin, which is used to treat a variety of bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, which is necessary for its survival. Without a functional cell wall, the bacteria are unable to grow and multiply, and are eventually destroyed by the body's immune system.

Cefuroxime is effective against many different types of bacteria, including both Gram-positive and Gram-negative organisms. It is often used to treat respiratory tract infections, urinary tract infections, skin and soft tissue infections, and bone and joint infections.

Like all antibiotics, cefuroxime should be used only under the direction of a healthcare provider, and it is important to take the full course of treatment as prescribed, even if symptoms improve before the medication is finished. Misuse of antibiotics can lead to the development of drug-resistant bacteria, which are more difficult to treat and can pose a serious threat to public health.

An immunization schedule is a series of planned dates when a person, usually a child, should receive specific vaccines in order to be fully protected against certain preventable diseases. The schedule is developed based on scientific research and recommendations from health organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC).

The immunization schedule outlines which vaccines are recommended, the number of doses required, the age at which each dose should be given, and the minimum amount of time that must pass between doses. The schedule may vary depending on factors such as the individual's age, health status, and travel plans.

Immunization schedules are important for ensuring that individuals receive timely protection against vaccine-preventable diseases, and for maintaining high levels of immunity in populations, which helps to prevent the spread of disease. It is important to follow the recommended immunization schedule as closely as possible to ensure optimal protection.

Lipopolysaccharides (LPS) are large molecules found in the outer membrane of Gram-negative bacteria. They consist of a hydrophilic polysaccharide called the O-antigen, a core oligosaccharide, and a lipid portion known as Lipid A. The Lipid A component is responsible for the endotoxic activity of LPS, which can trigger a powerful immune response in animals, including humans. This response can lead to symptoms such as fever, inflammation, and septic shock, especially when large amounts of LPS are introduced into the bloodstream.

Counterimmunoelectrophoresis (CIEP) is a laboratory technique used in the field of immunology and serology for the identification and detection of antigens or antibodies in a sample. It is a type of electrophoretic technique that involves the migration of antigens and antibodies in an electric field towards each other, resulting in the formation of a precipitin line at the point where they meet and react.

In CIEP, the antigen is placed in the gel matrix in a trough or well, while the antibody is placed in a separate trough located perpendicularly to the antigen trough. An electric current is then applied, causing both the antigens and antibodies to migrate towards each other through the gel matrix. When they meet, they form a precipitin line, which can be visualized as a white band or line in the gel.

CIEP is a rapid and sensitive technique that can be used to detect and identify specific antigens or antibodies in a sample. It is often used in the diagnosis of infectious diseases, autoimmune disorders, and other medical conditions where the presence of specific antigens or antibodies needs to be detected.

It's important to note that CIEP has been largely replaced by more modern techniques such as ELISA and Western blotting, which offer greater sensitivity and specificity. However, it is still used in some research and diagnostic settings due to its simplicity and cost-effectiveness.

Neisseria meningitidis is a Gram-negative, aerobic, bean-shaped diplococcus bacterium. It is one of the leading causes of bacterial meningitis and sepsis (known as meningococcal disease) worldwide. The bacteria can be found in the back of the nose and throat of approximately 10-25% of the general population, particularly in children, teenagers, and young adults, without causing any symptoms or illness. However, when the bacterium invades the bloodstream and spreads to the brain or spinal cord, it can lead to life-threatening infections such as meningitis (inflammation of the membranes surrounding the brain and spinal cord) and septicemia (blood poisoning).

Neisseria meningitidis is classified into 12 serogroups based on the chemical structure of their capsular polysaccharides. The six major serogroups that cause most meningococcal disease worldwide are A, B, C, W, X, and Y. Vaccines are available to protect against some or all of these serogroups.

Meningococcal disease can progress rapidly, leading to severe symptoms such as high fever, headache, stiff neck, confusion, nausea, vomiting, and a rash consisting of purple or red spots. Immediate medical attention is required if someone experiences these symptoms, as meningococcal disease can cause permanent disabilities or death within hours if left untreated.

Bacteriological techniques refer to the various methods and procedures used in the laboratory for the cultivation, identification, and study of bacteria. These techniques are essential in fields such as medicine, biotechnology, and research. Here are some common bacteriological techniques:

1. **Sterilization**: This is a process that eliminates or kills all forms of life, including bacteria, viruses, fungi, and spores. Common sterilization methods include autoclaving (using steam under pressure), dry heat (in an oven), chemical sterilants, and radiation.

2. **Aseptic Technique**: This refers to practices used to prevent contamination of sterile materials or environments with microorganisms. It includes the use of sterile equipment, gloves, and lab coats, as well as techniques such as flaming, alcohol swabbing, and using aseptic transfer devices.

3. **Media Preparation**: This involves the preparation of nutrient-rich substances that support bacterial growth. There are various types of media, including solid (agar), liquid (broth), and semi-solid (e.g., stab agar). The choice of medium depends on the type of bacteria being cultured and the purpose of the investigation.

4. **Inoculation**: This is the process of introducing a bacterial culture into a medium. It can be done using a loop, swab, or needle. The inoculum should be taken from a pure culture to avoid contamination.

5. **Incubation**: After inoculation, the bacteria are allowed to grow under controlled conditions of temperature, humidity, and atmospheric composition. This process is called incubation.

6. **Staining and Microscopy**: Bacteria are too small to be seen with the naked eye. Therefore, they need to be stained and observed under a microscope. Gram staining is a common method used to differentiate between two major groups of bacteria based on their cell wall composition.

7. **Biochemical Tests**: These are tests used to identify specific bacterial species based on their biochemical characteristics, such as their ability to ferment certain sugars, produce particular enzymes, or resist certain antibiotics.

8. **Molecular Techniques**: Advanced techniques like PCR and DNA sequencing can provide more precise identification of bacteria. They can also be used for genetic analysis and epidemiological studies.

Remember, handling microorganisms requires careful attention to biosafety procedures to prevent accidental infection or environmental contamination.

Genetic transformation is the process by which an organism's genetic material is altered or modified, typically through the introduction of foreign DNA. This can be achieved through various techniques such as:

* Gene transfer using vectors like plasmids, phages, or artificial chromosomes
* Direct uptake of naked DNA using methods like electroporation or chemically-mediated transfection
* Use of genome editing tools like CRISPR-Cas9 to introduce precise changes into the organism's genome.

The introduced DNA may come from another individual of the same species (cisgenic), from a different species (transgenic), or even be synthetically designed. The goal of genetic transformation is often to introduce new traits, functions, or characteristics that do not exist naturally in the organism, or to correct genetic defects.

This technique has broad applications in various fields, including molecular biology, biotechnology, and medical research, where it can be used to study gene function, develop genetically modified organisms (GMOs), create cell lines for drug screening, and even potentially treat genetic diseases through gene therapy.

Otitis media with effusion (OME), also known as serous otitis media or glue ear, is a medical condition characterized by the presence of fluid in the middle ear without signs or symptoms of acute ear infection. The fluid accumulation occurs due to the dysfunction of the Eustachian tube, which results in negative pressure and subsequent accumulation of sterile fluid within the middle ear space.

OME can lead to hearing difficulties, especially in children, as the fluid buildup impairs sound conduction through the ossicles in the middle ear. Symptoms may include mild hearing loss, tinnitus (ringing in the ears), and a sensation of fullness or pressure in the affected ear. In some cases, OME can resolve on its own within a few weeks or months; however, persistent cases might require medical intervention, such as placement of tympanostomy tubes (ear tubes) to drain the fluid and restore hearing.

Moraxellaceae is a family of Gram-negative, aerobic or facultatively anaerobic bacteria that are commonly found in the environment and on the mucosal surfaces of humans and animals. Infections caused by Moraxellaceae are relatively rare but can occur, particularly in individuals with weakened immune systems.

Two genera within this family, Moraxella and Acinetobacter, are most commonly associated with human infections. Moraxella catarrhalis is a leading cause of respiratory tract infections such as bronchitis, otitis media (middle ear infection), and sinusitis, particularly in children and the elderly. It can also cause conjunctivitis (pink eye) and pneumonia.

Acinetobacter species, on the other hand, are often found in soil and water and can colonize the skin and mucous membranes of humans without causing harm. However, they can become opportunistic pathogens in hospital settings, causing a range of infections such as pneumonia, bloodstream infections, wound infections, and meningitis, particularly in critically ill or immunocompromised patients.

Infections caused by Moraxellaceae can be treated with antibiotics, but the increasing prevalence of antibiotic-resistant strains is a growing concern. Proper infection control measures, such as hand hygiene and environmental cleaning, are essential to prevent the spread of these infections in healthcare settings.

Transferrin-binding proteins (TBPS) are a group of bacterial surface receptors that bind to transferrin, a glycoprotein involved in iron transport in mammals. These proteins are produced by certain pathogenic bacteria as a means to acquire iron from the host environment, which is essential for their growth and survival.

Transferrin sequesters iron in the bloodstream, making it unavailable to many invading microorganisms. However, some bacteria have evolved TBPS that can bind to transferrin and strip it of its iron, allowing them to use this vital nutrient for their own metabolic needs. The interaction between TBPS and transferrin is an important aspect of bacterial virulence and has been studied as a potential target for developing new antimicrobial therapies.

The epiglottis is a flap-like structure located at the base of the tongue, near the back of the throat (pharynx). It is made of elastic cartilage and covered with mucous membrane. The primary function of the epiglottis is to protect the trachea (windpipe) from food or liquids entering it during swallowing.

During normal swallowing, the epiglottis closes over the opening of the larynx (voice box), redirecting the food or liquid bolus into the esophagus. In this way, the epiglottis prevents aspiration, which is the entry of foreign materials into the trachea and lungs.

Inflammation or infection of the epiglottis can lead to a serious medical condition called epiglottitis, characterized by swelling, redness, and pain in the epiglottis and surrounding tissues. Epiglottitis can cause difficulty breathing, speaking, and swallowing, and requires immediate medical attention.

Poliovirus Vaccine, Inactivated (IPV) is a vaccine used to prevent poliomyelitis (polio), a highly infectious disease caused by the poliovirus. IPV contains inactivated (killed) polioviruses of all three poliovirus types. It works by stimulating an immune response in the body, but because the viruses are inactivated, they cannot cause polio. After vaccination, the immune system recognizes and responds to the inactivated viruses, producing antibodies that protect against future infection with wild, or naturally occurring, polioviruses. IPV is typically given as an injection in the leg or arm, and a series of doses are required for full protection. It is a safe and effective way to prevent polio and its complications.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Bacterial adhesins are proteins or structures on the surface of bacterial cells that allow them to attach to other cells or surfaces. This ability to adhere to host tissues is an important first step in the process of bacterial infection and colonization. Adhesins can recognize and bind to specific receptors on host cells, such as proteins or sugars, enabling the bacteria to establish a close relationship with the host and evade immune responses.

There are several types of bacterial adhesins, including fimbriae, pili, and non-fimbrial adhesins. Fimbriae and pili are thin, hair-like structures that extend from the bacterial surface and can bind to a variety of host cell receptors. Non-fimbrial adhesins are proteins that are directly embedded in the bacterial cell wall and can also mediate attachment to host cells.

Bacterial adhesins play a crucial role in the pathogenesis of many bacterial infections, including urinary tract infections, respiratory tract infections, and gastrointestinal infections. Understanding the mechanisms of bacterial adhesion is important for developing new strategies to prevent and treat bacterial infections.

Gardnerella vaginalis is a gram-variable, rod-shaped, non-motile bacterium that is part of the normal microbiota of the human vagina. However, an overgrowth of this organism can lead to a condition known as bacterial vaginosis (BV), which is characterized by a shift in the balance of vaginal flora, resulting in a decrease in beneficial lactobacilli and an increase in Gardnerella vaginalis and other anaerobic bacteria. This imbalance can cause symptoms such as abnormal vaginal discharge with a fishy odor, itching, and burning. It's important to note that while G. vaginalis is commonly associated with BV, its presence alone does not necessarily indicate the presence of the condition.

Bronchopneumonia is a type of pneumonia that involves inflammation and infection of the bronchioles (small airways in the lungs) and alveoli (tiny air sacs in the lungs). It can be caused by various bacteria, viruses, or fungi and often occurs as a complication of a respiratory tract infection.

The symptoms of bronchopneumonia may include cough, chest pain, fever, chills, shortness of breath, and fatigue. In severe cases, it can lead to complications such as respiratory failure or sepsis. Treatment typically involves antibiotics for bacterial infections, antiviral medications for viral infections, and supportive care such as oxygen therapy and hydration.

Pneumococcal infections are illnesses caused by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This bacterium can infect different parts of the body, including the lungs (pneumonia), blood (bacteremia or sepsis), and the covering of the brain and spinal cord (meningitis). Pneumococcal infections can also cause ear infections and sinus infections. The bacteria spread through close contact with an infected person, who may spread the bacteria by coughing or sneezing. People with weakened immune systems, children under 2 years of age, adults over 65, and those with certain medical conditions are at increased risk for developing pneumococcal infections.

Virulence, in the context of medicine and microbiology, refers to the degree or severity of damage or harm that a pathogen (like a bacterium, virus, fungus, or parasite) can cause to its host. It is often associated with the ability of the pathogen to invade and damage host tissues, evade or suppress the host's immune response, replicate within the host, and spread between hosts.

Virulence factors are the specific components or mechanisms that contribute to a pathogen's virulence, such as toxins, enzymes, adhesins, and capsules. These factors enable the pathogen to establish an infection, cause tissue damage, and facilitate its transmission between hosts. The overall virulence of a pathogen can be influenced by various factors, including host susceptibility, environmental conditions, and the specific strain or species of the pathogen.

Bacterial typing techniques are methods used to identify and differentiate bacterial strains or isolates based on their unique characteristics. These techniques are essential in epidemiological studies, infection control, and research to understand the transmission dynamics, virulence, and antibiotic resistance patterns of bacterial pathogens.

There are various bacterial typing techniques available, including:

1. **Bacteriophage Typing:** This method involves using bacteriophages (viruses that infect bacteria) to identify specific bacterial strains based on their susceptibility or resistance to particular phages.
2. **Serotyping:** It is a technique that differentiates bacterial strains based on the antigenic properties of their cell surface components, such as capsules, flagella, and somatic (O) and flagellar (H) antigens.
3. **Biochemical Testing:** This method uses biochemical reactions to identify specific metabolic pathways or enzymes present in bacterial strains, which can be used for differentiation. Commonly used tests include the catalase test, oxidase test, and various sugar fermentation tests.
4. **Molecular Typing Techniques:** These methods use genetic markers to identify and differentiate bacterial strains at the DNA level. Examples of molecular typing techniques include:
* **Pulsed-Field Gel Electrophoresis (PFGE):** This method uses restriction enzymes to digest bacterial DNA, followed by electrophoresis in an agarose gel under pulsed electrical fields. The resulting banding patterns are analyzed and compared to identify related strains.
* **Multilocus Sequence Typing (MLST):** It involves sequencing specific housekeeping genes to generate unique sequence types that can be used for strain identification and phylogenetic analysis.
* **Whole Genome Sequencing (WGS):** This method sequences the entire genome of a bacterial strain, providing the most detailed information on genetic variation and relatedness between strains. WGS data can be analyzed using various bioinformatics tools to identify single nucleotide polymorphisms (SNPs), gene deletions or insertions, and other genetic changes that can be used for strain differentiation.

These molecular typing techniques provide higher resolution than traditional methods, allowing for more accurate identification and comparison of bacterial strains. They are particularly useful in epidemiological investigations to track the spread of pathogens and identify outbreaks.

Cefotaxime is a third-generation cephalosporin antibiotic, which is used to treat a variety of bacterial infections. It works by inhibiting the synthesis of the bacterial cell wall. Cefotaxime has a broad spectrum of activity and is effective against many Gram-positive and Gram-negative bacteria, including some that are resistant to other antibiotics.

Cefotaxime is often used to treat serious infections such as pneumonia, meningitis, and sepsis. It may also be used to prevent infections during surgery or in people with weakened immune systems. The drug is administered intravenously or intramuscularly, and its dosage depends on the type and severity of the infection being treated.

Like all antibiotics, cefotaxime can cause side effects, including diarrhea, nausea, vomiting, and rash. In rare cases, it may cause serious allergic reactions or damage to the kidneys or liver. It is important to follow the prescribing physician's instructions carefully when taking this medication.

Amoxicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form cell walls, which is necessary for their growth and survival. By disrupting this process, amoxicillin can kill bacteria and help to clear up infections.

Amoxicillin is used to treat a variety of bacterial infections, including respiratory tract infections, ear infections, skin infections, and urinary tract infections. It is available as a tablet, capsule, chewable tablet, or liquid suspension, and is typically taken two to three times a day.

Like all antibiotics, amoxicillin should be used only under the direction of a healthcare provider, and it is important to take the full course of treatment as prescribed, even if symptoms improve before the medication is finished. Misuse of antibiotics can lead to the development of drug-resistant bacteria, which can make infections more difficult to treat in the future.

Erythromycin is a type of antibiotic known as a macrolide, which is used to treat various types of bacterial infections. It works by inhibiting the bacteria's ability to produce proteins, which are necessary for the bacteria to survive and multiply. Erythromycin is often used to treat respiratory tract infections, skin infections, and sexually transmitted diseases. It may also be used to prevent endocarditis (inflammation of the lining of the heart) in people at risk of this condition.

Erythromycin is generally considered safe for most people, but it can cause side effects such as nausea, vomiting, and diarrhea. It may also interact with other medications, so it's important to tell your doctor about all the drugs you are taking before starting erythromycin.

Like all antibiotics, erythromycin should only be used to treat bacterial infections, as it is not effective against viral infections such as the common cold or flu. Overuse of antibiotics can lead to antibiotic resistance, which makes it harder to treat infections in the future.

Chloramphenicol resistance is a type of antibiotic resistance in which bacteria have developed the ability to survive and grow in the presence of the antibiotic Chloramphenicol. This can occur due to genetic mutations or the acquisition of resistance genes from other bacteria through horizontal gene transfer.

There are several mechanisms by which bacteria can become resistant to Chloramphenicol, including:

1. Enzymatic inactivation: Some bacteria produce enzymes that can modify or degrade Chloramphenicol, rendering it ineffective.
2. Efflux pumps: Bacteria may develop efflux pumps that can actively pump Chloramphenicol out of the cell, reducing its intracellular concentration and preventing it from reaching its target site.
3. Target site alteration: Some bacteria may undergo mutations in their ribosomal RNA or proteins, which can prevent Chloramphenicol from binding to its target site and inhibiting protein synthesis.

Chloramphenicol resistance is a significant public health concern because it can limit the effectiveness of this important antibiotic in treating bacterial infections. It is essential to use Chloramphenicol judiciously and follow proper infection control practices to prevent the spread of resistant bacteria.

The pharynx is a part of the digestive and respiratory systems that serves as a conduit for food and air. It is a musculo-membranous tube extending from the base of the skull to the level of the sixth cervical vertebra where it becomes continuous with the esophagus.

The pharynx has three regions: the nasopharynx, oropharynx, and laryngopharynx. The nasopharynx is the uppermost region, which lies above the soft palate and is connected to the nasal cavity. The oropharynx is the middle region, which includes the area between the soft palate and the hyoid bone, including the tonsils and base of the tongue. The laryngopharynx is the lowest region, which lies below the hyoid bone and connects to the larynx.

The primary function of the pharynx is to convey food from the oral cavity to the esophagus during swallowing and to allow air to pass from the nasal cavity to the larynx during breathing. It also plays a role in speech, taste, and immune defense.

Azithromycin is a widely used antibiotic drug that belongs to the class of macrolides. It works by inhibiting bacterial protein synthesis, which leads to the death of susceptible bacteria. This medication is active against a broad range of gram-positive and gram-negative bacteria, atypical bacteria, and some parasites.

Azithromycin is commonly prescribed to treat various bacterial infections, such as:

1. Respiratory tract infections, including pneumonia, bronchitis, and sinusitis
2. Skin and soft tissue infections
3. Sexually transmitted diseases, like chlamydia
4. Otitis media (middle ear infection)
5. Traveler's diarrhea

The drug is available in various forms, including tablets, capsules, suspension, and intravenous solutions. The typical dosage for adults ranges from 250 mg to 500 mg per day, depending on the type and severity of the infection being treated.

Like other antibiotics, azithromycin should be used judiciously to prevent antibiotic resistance. It is essential to complete the full course of treatment as prescribed by a healthcare professional, even if symptoms improve before finishing the medication.

Species specificity is a term used in the field of biology, including medicine, to refer to the characteristic of a biological entity (such as a virus, bacterium, or other microorganism) that allows it to interact exclusively or preferentially with a particular species. This means that the biological entity has a strong affinity for, or is only able to infect, a specific host species.

For example, HIV is specifically adapted to infect human cells and does not typically infect other animal species. Similarly, some bacterial toxins are species-specific and can only affect certain types of animals or humans. This concept is important in understanding the transmission dynamics and host range of various pathogens, as well as in developing targeted therapies and vaccines.

Bacterial conjunctivitis is a type of conjunctivitis (inflammation of the conjunctiva) that is caused by bacterial infection. The most common bacteria responsible for this condition are Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae.

The symptoms of bacterial conjunctivitis include redness, swelling, and pain in the eye, along with a thick, sticky discharge that can cause the eyelids to stick together, especially upon waking up. Other symptoms may include tearing, itching, and sensitivity to light. Bacterial conjunctivitis is highly contagious and can spread easily through contact with infected individuals or contaminated objects such as towels, handkerchiefs, or makeup.

Treatment for bacterial conjunctivitis typically involves the use of antibiotic eye drops or ointments to eliminate the infection. In some cases, oral antibiotics may also be prescribed. It is important to seek medical attention if you suspect that you have bacterial conjunctivitis, as untreated infections can lead to serious complications such as corneal ulcers and vision loss.

Vaccination is a simple, safe, and effective way to protect people against harmful diseases, before they come into contact with them. It uses your body's natural defenses to build protection to specific infections and makes your immune system stronger.

A vaccination usually contains a small, harmless piece of a virus or bacteria (or toxins produced by these germs) that has been made inactive or weakened so it won't cause the disease itself. This piece of the germ is known as an antigen. When the vaccine is introduced into the body, the immune system recognizes the antigen as foreign and produces antibodies to fight it.

If a person then comes into contact with the actual disease-causing germ, their immune system will recognize it and immediately produce antibodies to destroy it. The person is therefore protected against that disease. This is known as active immunity.

Vaccinations are important for both individual and public health. They prevent the spread of contagious diseases and protect vulnerable members of the population, such as young children, the elderly, and people with weakened immune systems who cannot be vaccinated or for whom vaccination is not effective.

Sputum is defined as a mixture of saliva and phlegm that is expelled from the respiratory tract during coughing, sneezing or deep breathing. It can be clear, mucoid, or purulent (containing pus) depending on the underlying cause of the respiratory issue. Examination of sputum can help diagnose various respiratory conditions such as infections, inflammation, or other lung diseases.

Bacterial fimbriae are thin, hair-like protein appendages that extend from the surface of many types of bacteria. They are involved in the attachment of bacteria to surfaces, other cells, or extracellular structures. Fimbriae enable bacteria to adhere to host tissues and form biofilms, which contribute to bacterial pathogenicity and survival in various environments. These protein structures are composed of several thousand subunits of a specific protein called pilin. Some fimbriae can recognize and bind to specific receptors on host cells, initiating the process of infection and colonization.

Trimethoprim is an antibiotic medication that is primarily used to treat bacterial infections. It works by inhibiting the bacterial enzyme dihydrofolate reductase, which is necessary for the synthesis of DNA and protein. This leads to bacterial cell death. Trimethoprim is often combined with sulfamethoxazole (a sulfonamide antibiotic) to create a more effective antibacterial therapy known as co-trimoxazole or TMP-SMX.

Medical Definition:
Trimethoprim is a synthetic antibacterial drug that selectively inhibits bacterial dihydrofolate reductase, an enzyme required for the synthesis of tetrahydrofolate, a cofactor involved in the biosynthesis of thymidine and purines. By blocking this essential pathway, trimethoprim disrupts bacterial DNA and protein synthesis, leading to bacteriostatic activity against many gram-positive and gram-negative bacteria. Trimethoprim is often combined with sulfamethoxazole (a sulfonamide antibiotic) to create a more effective antibacterial therapy known as co-trimoxazole or TMP-SMX, which inhibits two consecutive steps in the bacterial folate synthesis pathway.

Bronchitis is a medical condition characterized by inflammation of the bronchi, which are the large airways that lead to the lungs. This inflammation can cause a variety of symptoms, including coughing, wheezing, chest tightness, and shortness of breath. Bronchitis can be either acute or chronic.

Acute bronchitis is usually caused by a viral infection, such as a cold or the flu, and typically lasts for a few days to a week. Symptoms may include a productive cough (coughing up mucus or phlegm), chest discomfort, and fatigue. Acute bronchitis often resolves on its own without specific medical treatment, although rest, hydration, and over-the-counter medications to manage symptoms may be helpful.

Chronic bronchitis, on the other hand, is a long-term condition that is characterized by a persistent cough with mucus production that lasts for at least three months out of the year for two consecutive years. Chronic bronchitis is typically caused by exposure to irritants such as cigarette smoke, air pollution, or occupational dusts and chemicals. It is often associated with chronic obstructive pulmonary disease (COPD), which includes both chronic bronchitis and emphysema.

Treatment for chronic bronchitis may include medications to help open the airways, such as bronchodilators and corticosteroids, as well as lifestyle changes such as smoking cessation and avoiding irritants. In severe cases, oxygen therapy or lung transplantation may be necessary.

Clavulanic acid is not a medical condition, but rather an antibacterial compound that is often combined with certain antibiotics to increase their effectiveness against bacteria that have become resistant to the antibiotic alone. It works by inhibiting certain enzymes produced by bacteria that help them to resist the antibiotic, allowing the antibiotic to work more effectively.

Clavulanic acid is typically combined with antibiotics such as amoxicillin or ticarcillin to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, and skin and soft tissue infections. It is important to note that clavulanate-containing medications should only be used under the direction of a healthcare provider, as misuse or overuse can contribute to antibiotic resistance.

Cefixime is a third-generation cephalosporin antibiotic, which is used to treat various bacterial infections. It works by inhibiting the synthesis of the bacterial cell wall. Cefixime is available as an oral suspension or tablet and is commonly prescribed for respiratory tract infections, urinary tract infections, ear infections, and skin infections.

The medical definition of Cefixime can be stated as follows:

Cefixime: A semisynthetic antibiotic derived from cephalosporin, which is used to treat a variety of bacterial infections. It has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, including beta-lactamase producing strains. Cefixime is administered orally and is often prescribed for respiratory tract infections, urinary tract infections, ear infections, and skin infections. It has a long half-life and high oral bioavailability, making it a convenient option for outpatient treatment.

Common side effects of Cefixime include diarrhea, nausea, vomiting, abdominal pain, and headache. Serious side effects are rare but may include anaphylaxis, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Caution should be exercised when prescribing Cefixime to patients with a history of allergic reactions to cephalosporins or penicillins.

Ketolides are a class of antibiotics, which are chemically modified versions of macrolide antibiotics. They have an extended spectrum of activity and improved stability against bacterial resistance mechanisms compared to older macrolides. Ketolides inhibit protein synthesis in bacteria by binding to the 50S ribosomal subunit.

The main ketolide antibiotics include telithromycin, cethromycin, and solithromycin. They are primarily used for treating respiratory tract infections caused by susceptible strains of bacteria, including drug-resistant pneumococci and atypical pathogens like Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydia pneumoniae.

It is important to note that ketolides have potential side effects, such as gastrointestinal disturbances, liver enzyme elevations, and cardiac arrhythmias, which should be considered when prescribing them.

Female urogenital diseases refer to a range of medical conditions that affect the female urinary and genital systems. These systems include the kidneys, ureters, bladder, urethra, vulva, vagina, and reproductive organs such as the ovaries and uterus.

Some common female urogenital diseases include:

1. Urinary tract infections (UTIs): These are infections that occur in any part of the urinary system, including the kidneys, ureters, bladder, or urethra.
2. Pelvic inflammatory disease (PID): This is an infection of the reproductive organs, including the uterus, fallopian tubes, and ovaries.
3. Endometriosis: This is a condition in which tissue similar to the lining of the uterus grows outside of the uterus, often on the ovaries, fallopian tubes, or other pelvic structures.
4. Ovarian cysts: These are fluid-filled sacs that form on the ovaries.
5. Uterine fibroids: These are noncancerous growths that develop in the muscular wall of the uterus.
6. Interstitial cystitis/bladder pain syndrome (IC/BPS): This is a chronic bladder condition characterized by pain, pressure, and discomfort in the bladder and pelvic area.
7. Sexually transmitted infections (STIs): These are infections that are passed from person to person during sexual contact. Common STIs include chlamydia, gonorrhea, syphilis, and HIV.
8. Vulvodynia: This is chronic pain or discomfort of the vulva, the external female genital area.
9. Cancers of the reproductive system, such as ovarian cancer, cervical cancer, and uterine cancer.

These are just a few examples of female urogenital diseases. It's important for women to receive regular medical care and screenings to detect and treat these conditions early, when they are often easier to manage and have better outcomes.

In the context of medical laboratory reporting, "R factors" refer to a set of values that describe the resistance of certain bacteria to different antibiotics. These factors are typically reported as R1, R2, R3, and so on, where each R factor corresponds to a specific antibiotic or class of antibiotics.

An R factor value of "1" indicates susceptibility to the corresponding antibiotic, while an R factor value of "R" (or "R-", depending on the laboratory's reporting practices) indicates resistance. An intermediate category may also be reported as "I" or "I-", indicating that the bacterium is intermediately sensitive to the antibiotic in question.

It's important to note that R factors are just one piece of information used to guide clinical decision-making around antibiotic therapy, and should be interpreted in conjunction with other factors such as the patient's clinical presentation, the severity of their infection, and any relevant guidelines or recommendations from infectious disease specialists.

Cefamandole is a second-generation cephalosporin antibiotic, which is a type of antibacterial medication used to treat various infections caused by bacteria. It works by interfering with the ability of bacteria to form cell walls, resulting in weakening and eventual death of the bacterial cells.

Cefamandole has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, making it useful for treating a variety of infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, and septicemia.

Like other cephalosporins, cefamandole is generally well-tolerated and has a low incidence of serious side effects. However, it can cause gastrointestinal symptoms such as nausea, vomiting, and diarrhea, as well as allergic reactions in some people. It may also interact with other medications, so it's important to inform your healthcare provider of all the medications you are taking before starting cefamandole therapy.

It is important to note that antibiotics should only be used to treat bacterial infections and not viral infections, as they are not effective against viruses and can contribute to the development of antibiotic resistance.

'Escherichia coli' (E. coli) is a type of gram-negative, facultatively anaerobic, rod-shaped bacterium that commonly inhabits the intestinal tract of humans and warm-blooded animals. It is a member of the family Enterobacteriaceae and one of the most well-studied prokaryotic model organisms in molecular biology.

While most E. coli strains are harmless and even beneficial to their hosts, some serotypes can cause various forms of gastrointestinal and extraintestinal illnesses in humans and animals. These pathogenic strains possess virulence factors that enable them to colonize and damage host tissues, leading to diseases such as diarrhea, urinary tract infections, pneumonia, and sepsis.

E. coli is a versatile organism with remarkable genetic diversity, which allows it to adapt to various environmental niches. It can be found in water, soil, food, and various man-made environments, making it an essential indicator of fecal contamination and a common cause of foodborne illnesses. The study of E. coli has contributed significantly to our understanding of fundamental biological processes, including DNA replication, gene regulation, and protein synthesis.

Anti-infective agents are a class of medications that are used to treat infections caused by various microorganisms such as bacteria, viruses, fungi, and parasites. These agents work by either killing the microorganism or inhibiting its growth, thereby helping to control the infection and alleviate symptoms.

There are several types of anti-infective agents, including:

1. Antibiotics: These are medications that are used to treat bacterial infections. They work by either killing bacteria (bactericidal) or inhibiting their growth (bacteriostatic).
2. Antivirals: These are medications that are used to treat viral infections. They work by interfering with the replication of the virus, preventing it from spreading and causing further damage.
3. Antifungals: These are medications that are used to treat fungal infections. They work by disrupting the cell membrane of the fungus, killing it or inhibiting its growth.
4. Antiparasitics: These are medications that are used to treat parasitic infections. They work by either killing the parasite or inhibiting its growth and reproduction.

It is important to note that anti-infective agents are not effective against all types of infections, and it is essential to use them appropriately to avoid the development of drug-resistant strains of microorganisms.

Pneumococcal meningitis is a specific type of bacterial meningitis, which is an inflammation of the membranes covering the brain and spinal cord (meninges). It is caused by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This bacterium is commonly found in the upper respiratory tract and middle ear fluid of healthy individuals. However, under certain circumstances, it can invade the bloodstream and reach the meninges, leading to meningitis.

Pneumococcal meningitis is a serious and potentially life-threatening condition that requires immediate medical attention. Symptoms may include sudden onset of fever, severe headache, stiff neck, nausea, vomiting, confusion, and sensitivity to light (photophobia). In some cases, it can also lead to complications such as hearing loss, brain damage, or even death if not treated promptly and effectively.

Treatment typically involves the use of antibiotics that are effective against pneumococcus, such as ceftriaxone or vancomycin. In some cases, corticosteroids may also be used to reduce inflammation and prevent complications. Prevention measures include vaccination with the pneumococcal conjugate vaccine (PCV13) or the pneumococcal polysaccharide vaccine (PPSV23), which can help protect against pneumococcal infections, including meningitis.

Bacterial pneumonia is a type of lung infection that's caused by bacteria. It can affect people of any age, but it's more common in older adults, young children, and people with certain health conditions or weakened immune systems. The symptoms of bacterial pneumonia can vary, but they often include cough, chest pain, fever, chills, and difficulty breathing.

The most common type of bacteria that causes pneumonia is Streptococcus pneumoniae (pneumococcus). Other types of bacteria that can cause pneumonia include Haemophilus influenzae, Staphylococcus aureus, and Mycoplasma pneumoniae.

Bacterial pneumonia is usually treated with antibiotics, which are medications that kill bacteria. The specific type of antibiotic used will depend on the type of bacteria causing the infection. It's important to take all of the prescribed medication as directed, even if you start feeling better, to ensure that the infection is completely cleared and to prevent the development of antibiotic resistance.

In severe cases of bacterial pneumonia, hospitalization may be necessary for close monitoring and treatment with intravenous antibiotics and other supportive care.

Penicillin-Binding Proteins (PBPs) are essential bacterial enzymes that play a crucial role in the synthesis and maintenance of the bacterial cell wall. They are called "penicillin-binding" because they possess the ability to bind to penicillin and other beta-lactam antibiotics, which subsequently inhibits their function and leads to the death of the bacteria. PBPs are primary targets for many clinically important antibiotics, including penicillins, cephalosporins, and carbapenems. Inhibition of these proteins interferes with the cross-linking of peptidoglycan in the bacterial cell wall, causing structural weakness and osmotic lysis of the bacteria.

Bacterial infections are caused by the invasion and multiplication of bacteria in or on tissues of the body. These infections can range from mild, like a common cold, to severe, such as pneumonia, meningitis, or sepsis. The symptoms of a bacterial infection depend on the type of bacteria invading the body and the area of the body that is affected.

Bacteria are single-celled microorganisms that can live in many different environments, including in the human body. While some bacteria are beneficial to humans and help with digestion or protect against harmful pathogens, others can cause illness and disease. When bacteria invade the body, they can release toxins and other harmful substances that damage tissues and trigger an immune response.

Bacterial infections can be treated with antibiotics, which work by killing or inhibiting the growth of bacteria. However, it is important to note that misuse or overuse of antibiotics can lead to antibiotic resistance, making treatment more difficult. It is also essential to complete the full course of antibiotics as prescribed, even if symptoms improve, to ensure that all bacteria are eliminated and reduce the risk of recurrence or development of antibiotic resistance.

Gram-negative bacteria are a type of bacteria that do not retain the crystal violet stain used in the Gram staining method, a standard technique used in microbiology to classify and identify different types of bacteria based on their structural differences. This method was developed by Hans Christian Gram in 1884.

The primary characteristic distinguishing Gram-negative bacteria from Gram-positive bacteria is the composition and structure of their cell walls:

1. Cell wall: Gram-negative bacteria have a thin peptidoglycan layer, making it more susceptible to damage and less rigid compared to Gram-positive bacteria.
2. Outer membrane: They possess an additional outer membrane that contains lipopolysaccharides (LPS), which are endotoxins that can trigger strong immune responses in humans and animals. The outer membrane also contains proteins, known as porins, which form channels for the passage of molecules into and out of the cell.
3. Periplasm: Between the inner and outer membranes lies a compartment called the periplasm, where various enzymes and other molecules are located.

Some examples of Gram-negative bacteria include Escherichia coli (E. coli), Pseudomonas aeruginosa, Klebsiella pneumoniae, Salmonella enterica, Shigella spp., and Neisseria meningitidis. These bacteria are often associated with various infections, such as urinary tract infections, pneumonia, sepsis, and meningitis. Due to their complex cell wall structure, Gram-negative bacteria can be more resistant to certain antibiotics, making them a significant concern in healthcare settings.

Agglutination tests are laboratory diagnostic procedures used to detect the presence of antibodies or antigens in a sample, such as blood or serum. These tests work by observing the clumping (agglutination) of particles, like red blood cells or bacteriophages, coated with specific antigens or antibodies when mixed with a patient's sample.

In an agglutination test, the sample is typically combined with a reagent containing known antigens or antibodies on the surface of particles, such as latex beads, red blood cells, or bacteriophages. If the sample contains the corresponding antibodies or antigens, they will bind to the particles, forming visible clumps or agglutinates. The presence and strength of agglutination are then assessed visually or with automated equipment to determine the presence and quantity of the target antigen or antibody in the sample.

Agglutination tests are widely used in medical diagnostics for various applications, including:

1. Bacterial and viral infections: To identify specific bacterial or viral antigens in a patient's sample, such as group A Streptococcus, Legionella pneumophila, or HIV.
2. Blood typing: To determine the ABO blood group and Rh type of a donor or recipient before a blood transfusion or organ transplantation.
3. Autoimmune diseases: To detect autoantibodies in patients with suspected autoimmune disorders, such as rheumatoid arthritis, systemic lupus erythematosus, or Hashimoto's thyroiditis.
4. Allergies: To identify specific IgE antibodies in a patient's sample to determine allergic reactions to various substances, such as pollen, food, or venom.
5. Drug monitoring: To detect and quantify the presence of drug-induced antibodies, such as those developed in response to penicillin or hydralazine therapy.

Agglutination tests are simple, rapid, and cost-effective diagnostic tools that provide valuable information for clinical decision-making and patient management. However, they may have limitations, including potential cross-reactivity with other antigens, false-positive results due to rheumatoid factors or heterophile antibodies, and false-negative results due to the prozone effect or insufficient sensitivity. Therefore, it is essential to interpret agglutination test results in conjunction with clinical findings and other laboratory data.

Molecular cloning is a laboratory technique used to create multiple copies of a specific DNA sequence. This process involves several steps:

1. Isolation: The first step in molecular cloning is to isolate the DNA sequence of interest from the rest of the genomic DNA. This can be done using various methods such as PCR (polymerase chain reaction), restriction enzymes, or hybridization.
2. Vector construction: Once the DNA sequence of interest has been isolated, it must be inserted into a vector, which is a small circular DNA molecule that can replicate independently in a host cell. Common vectors used in molecular cloning include plasmids and phages.
3. Transformation: The constructed vector is then introduced into a host cell, usually a bacterial or yeast cell, through a process called transformation. This can be done using various methods such as electroporation or chemical transformation.
4. Selection: After transformation, the host cells are grown in selective media that allow only those cells containing the vector to grow. This ensures that the DNA sequence of interest has been successfully cloned into the vector.
5. Amplification: Once the host cells have been selected, they can be grown in large quantities to amplify the number of copies of the cloned DNA sequence.

Molecular cloning is a powerful tool in molecular biology and has numerous applications, including the production of recombinant proteins, gene therapy, functional analysis of genes, and genetic engineering.

Penicillins are a group of antibiotics derived from the Penicillium fungus. They are widely used to treat various bacterial infections due to their bactericidal activity, which means they kill bacteria by interfering with the synthesis of their cell walls. The first penicillin, benzylpenicillin (also known as penicillin G), was discovered in 1928 by Sir Alexander Fleming. Since then, numerous semi-synthetic penicillins have been developed to expand the spectrum of activity and stability against bacterial enzymes that can inactivate these drugs.

Penicillins are classified into several groups based on their chemical structure and spectrum of activity:

1. Natural Penicillins (e.g., benzylpenicillin, phenoxymethylpenicillin): These have a narrow spectrum of activity, mainly targeting Gram-positive bacteria such as streptococci and staphylococci. However, they are susceptible to degradation by beta-lactamase enzymes produced by some bacteria.
2. Penicillinase-resistant Penicillins (e.g., methicillin, oxacillin, nafcillin): These penicillins resist degradation by certain bacterial beta-lactamases and are primarily used to treat infections caused by staphylococci, including methicillin-susceptible Staphylococcus aureus (MSSA).
3. Aminopenicillins (e.g., ampicillin, amoxicillin): These penicillins have an extended spectrum of activity compared to natural penicillins, including some Gram-negative bacteria such as Escherichia coli and Haemophilus influenzae. However, they are still susceptible to degradation by many beta-lactamases.
4. Antipseudomonal Penicillins (e.g., carbenicillin, ticarcillin): These penicillins have activity against Pseudomonas aeruginosa and other Gram-negative bacteria with increased resistance to other antibiotics. They are often combined with beta-lactamase inhibitors such as clavulanate or tazobactam to protect them from degradation.
5. Extended-spectrum Penicillins (e.g., piperacillin): These penicillins have a broad spectrum of activity, including many Gram-positive and Gram-negative bacteria. They are often combined with beta-lactamase inhibitors to protect them from degradation.

Penicillins are generally well-tolerated antibiotics; however, they can cause allergic reactions in some individuals, ranging from mild skin rashes to life-threatening anaphylaxis. Cross-reactivity between different penicillin classes and other beta-lactam antibiotics (e.g., cephalosporins) is possible but varies depending on the specific drugs involved.

Bacterial drug resistance is a type of antimicrobial resistance that occurs when bacteria evolve the ability to survive and reproduce in the presence of drugs (such as antibiotics) that would normally kill them or inhibit their growth. This can happen due to various mechanisms, including genetic mutations or the acquisition of resistance genes from other bacteria.

As a result, bacterial infections may become more difficult to treat, requiring higher doses of medication, alternative drugs, or longer treatment courses. In some cases, drug-resistant infections can lead to serious health complications, increased healthcare costs, and higher mortality rates.

Examples of bacterial drug resistance include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), and multidrug-resistant tuberculosis (MDR-TB). Preventing the spread of bacterial drug resistance is crucial for maintaining effective treatments for infectious diseases.

Neisseriaceae infections refer to illnesses caused by bacteria belonging to the family Neisseriaceae, which includes several genera of gram-negative diplococci. The most common pathogens in this family are Neisseria gonorrhoeae and Neisseria meningitidis.

* N. gonorrhoeae is the causative agent of gonorrhea, a sexually transmitted infection that can affect the genital tract, rectum, and throat. It can also cause conjunctivitis in newborns who contract the bacteria during childbirth.
* N. meningitidis is responsible for meningococcal disease, which can present as meningitis (inflammation of the membranes surrounding the brain and spinal cord) or septicemia (bloodstream infection). Meningococcal disease can be severe and potentially life-threatening, with symptoms including high fever, headache, stiff neck, and a rash.

Other Neisseriaceae species that can cause human infections, though less commonly, include Moraxella catarrhalis (a cause of respiratory tract infections, particularly in children), Kingella kingae (associated with bone and joint infections in young children), and various other Neisseria species (which can cause skin and soft tissue infections, endocarditis, and other invasive diseases).

A plasmid is a small, circular, double-stranded DNA molecule that is separate from the chromosomal DNA of a bacterium or other organism. Plasmids are typically not essential for the survival of the organism, but they can confer beneficial traits such as antibiotic resistance or the ability to degrade certain types of pollutants.

Plasmids are capable of replicating independently of the chromosomal DNA and can be transferred between bacteria through a process called conjugation. They often contain genes that provide resistance to antibiotics, heavy metals, and other environmental stressors. Plasmids have also been engineered for use in molecular biology as cloning vectors, allowing scientists to replicate and manipulate specific DNA sequences.

Plasmids are important tools in genetic engineering and biotechnology because they can be easily manipulated and transferred between organisms. They have been used to produce vaccines, diagnostic tests, and genetically modified organisms (GMOs) for various applications, including agriculture, medicine, and industry.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

"Haemophilus influenzae type a infection and its prevention". Infection and Immunity. 75 (6): 2650-2654. doi:10.1128/IAI.01774- ... "Haemophilus Influenzae Infections: Practice Essentials, Background, Pathophysiology". Medscape. "Haemophilus Influenzae". ... eye infections and bloodstream infection, meningitis. It can also cause cellulitis (skin infection) and infectious arthritis ( ... Haemophilus influenzae can cause respiratory tract infections including pneumonia, otitis media, epiglottitis (swelling in the ...
Infection with Haemophilus influenzae can cause chest pain. Since most causes of pediatric and adolescent chest pain are not ... Yeh, Y-H; Chu, P-H; Yeh, C-H; Jan Wu, Y-J; Lee, M-H.; Jung, S-M; Kuo, C-T (2004). "Haemophilus influenzae pericarditis with ...
A C1-INH concentrate can be used for angio-oedema (C1-INH deficiency). Pneumococcus and Haemophilus infections can be prevented ... Acquired hypocomplementemia may occur in the setting of bone infections (osteomyelitis), infection of the lining of the heart ( ... The cause of complement deficiency is genetics (though cases of an acquired nature do exist post infection). The majority of ... Ram, S.; Lewis, L. A.; Rice, P. A. (7 October 2010). "Infections of People with Complement Deficiencies and Patients Who Have ...
Haemophilus ducreyi infections can cause skin conditions that mimic primary yaws. People infected with Haemophilus ducreyi ... It seems that a recently diverged strain of Haemophilus ducreyi has evolved from being a sexually transmitted infection to ... Lewis, David A.; Mitjà, Oriol (February 2016). "Haemophilus ducreyi: from sexually transmitted infection to skin ulcer pathogen ... Almost 85% of infections occurred in three countries-Ghana, Papua New Guinea, and Solomon Islands. The disease only infects ...
Lewis, DA; Mitjà, O (February 2016). "Haemophilus ducreyi: from sexually transmitted infection to skin ulcer pathogen". Current ... "Haemophilus ducreyi (Chancroid) - Infectious Disease and Antimicrobial Agents". Haemophilus ducreyi at the NCBI Taxonomy ... Haemophilus ducreyi are fastidious gram-negative coccobacilli bacteria. This species causes the sexually transmitted disease ... Inflammation then takes place as the area of infection is inundated with lymphocytes, macrophages, and granulocytes. This ...
The most common bacterial infection is caused by Haemophilus influenzae. Other risks include exposure to tobacco smoke (active ... Other respiratory infections may be bacterial or in combination sometimes secondary to a viral infection. ... There has also been a marked decrease in the number of cold and flu infections during this time. Smoke from wildfires is ... The usual cause of an exacerbation is a viral infection, most often the common cold. The common cold is usually associated with ...
It may be associated with immunosuppression, trichomonas, or Haemophilus vaginalis infection. Vaginitis emphysematous is ... This is characterised by gas-filled cysts in the vaginal wall and does not imply life-threatening infection. Vaginitis ... Al, A; Al, H; Ramesh, V (April 2002). "Vaginitis emphysematosa". Sexually Transmitted Infections. 78 (2): 155. doi:10.1136/sti. ...
Bowerman SG, Green NE, Mencio GA (August 1997). "Decline of bone and joint infections attributable to haemophilus influenzae ... Gram negative infections are usually acquired through urinary tract infections, drug abuse, and skin infections. Older people ... Microorganisms in the blood may come from infections elsewhere in the body such as wound infections, urinary tract infections, ... There are three phases of artificial joint infection: early, delayed and late. Early - infection occurs in less than 3 months. ...
It has been observed to play a role in Haemophilus influenzae infections. Studies showed that bacterium can adhere to this ... "The Anton blood group antigen is the erythrocyte receptor for Haemophilus influenzae". FEMS Microbiology Letters. 37 (1): 69-71 ...
Gardner, Herman; Dukes, Charles (May 1955). "Haemophilus vaginalis vaginitis: A newly defined specific infection previously ... This bacterial infection is characterized by a foul, fishy smelling, thin gray vaginal discharge, and an increase in vaginal pH ...
"Haemophilus pittmaniae respiratory infection in a patient with siderosis: a case report". Journal of Medical Case Reports. 6 (1 ... "Multilocus sequence phylogenetic study of the genus Haemophilus with description of Haemophilus pittmaniae sp. nov". ... Haemophilus pittmaniae is a Gram-negative species of bacterium of the family Pasteurellaceae. Strains of this species were ... Type strain of Haemophilus pittmaniae at BacDive - the Bacterial Diversity Metadatabase Portal: Biology v t e (Articles with ...
Haemophilus influenzae is an opportunistic bacterium which commonly follows influenza infections; this led the eminent German ... But, unlike other viral infections, the incidence of polio - the rarer severe form of the infection - increased in the 20th ... Many bacteriologists soon discovered the cause of numerous infections. However, some infections remained, many of them ... Ivanovsky suggested the infection might be caused by a toxin produced by bacteria, but did not pursue the idea. In 1898, the ...
Haemophilus influenzae), and some respiratory tract and soft-tissue infections. The antimicrobial spectrum of macrolides is ... This is evident, as the treatment dosage is much too low to fight infection, and in DPB cases with the occurrence of the ... Azithromycin has been used to treat strep throat (Group A streptococcal (GAS) infection caused by Streptococcus pyogenes) in ... Macrolides are actively concentrated within leukocytes, and thus are transported into the site of infection. The macrolide ...
Present with recurrent infections with Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, hepatitis virus ... With treatment, the number and severity of infections is reduced. With IVIg, XLA patients may live a relatively healthy life. A ... Patients with untreated XLA are prone to develop serious and even fatal infections. A mutation occurs at the Bruton's tyrosine ... Although the symptoms of a XLA and other primary immune diseases (PID) include repeated and often severe infections, the ...
... and infections by Haemophilus influenzae. It is also used as adjunct therapy for chloroquine-resistant malaria and several ... For urinary tract infections, the usual dose is 4 to 6 grams daily in 3 to 6 divided doses. Common side effects include nausea ... It eliminates bacteria that cause infections by stopping the production of folate inside the bacterial cell, and is commonly ... used to treat urinary tract infections and burns. In combination, sulfadiazine and pyrimethamine can be used to treat ...
"Induction of Mucosal IgA-Mediated Protective Immunity Against Nontypeable Haemophilus influenzae Infection by a Cationic ... As a result, this vaccine can have the potential to treat ear infections caused by biofilm from influenza infection. New ... As all three of these viruses are related to respiratory infection, using an intranasal route can bring the vaccine directly to ... The antigen in the nasal vaccine can then trigger an immune response and prevent infection due to nasal vaccines' accessibility ...
Rifampin prophylaxis for day care contacts of patients with serious Haemophilus influenzae type b infections". The Journal of ... "Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine". The Journal of ... Osterholm, M. T.; Kuritsky, J. N.; Murphy, T. V.; Mead, W. C. (1985-05-10). "Haemophilus influenzae type b in day care centers ... Ginsburg, C. M.; McCracken, G. H.; Rae, S.; Parke, J. C. (1977-08-15). "Haemophilus influenzae type b disease. Incidence in a ...
It is also sometimes used to treat infections by Listeria species, Neisseria gonorrhoeae, Haemophilus influenzae, and ... for latent TB infection; and when used as post-exposure prophylaxis to prevent Haemophilus influenzae type b and meningococcal ... including in difficult-to-treat infections such as osteomyelitis and prosthetic joint infections. As of 2012, if rifampicin ... Rifampicin can be used alone in patients with latent tuberculosis infections to prevent or delay the development of active ...
Slack MP, Cripps AW, Grimwood K, Mackenzie GA, Ulanova M (June 2021). "Invasive Haemophilus influenzae Infections after 3 ... The Haemophilus influenzae type B vaccine, also known as Hib vaccine, is a vaccine used to prevent Haemophilus influenzae type ... Broome CV (August 1987). "Epidemiology of Haemophilus influenzae type b infections in the United States". The Pediatric ... "Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months ...
Skin ulcers can resemble those caused by leishmaniasis, yaws, squamous cell carcinoma, Haemophilus ducreyi infection, and ... M. ulcerans infection can cause Buruli ulcer-like lesions in some non-human animals. Natural non-human infections have only ... ulcerans infection. As of 2019, no vaccine tested completely protects mice from infection. M. ulcerans can be grown in ... The first sign of infection is a small painless nodule or area of swelling, typically on the arms or legs. The nodule grows ...
... was elevated in patients with Haemophilus influenzae airway infection compared to Pseudomonas aeruginosa airway infection. ... Bronchiectasis patients with P. aeruginosa infection have a more rapid decline in lung function. Disease-causing mutations in ...
Many pigs affected by the circovirus also seem to develop secondary bacterial infections, like Glässer disease (Haemophilus ... However, viral infection by itself tends to cause only mild disease, and co-factors such as other infections or ... Experimental induction of PMWS has not been achieved by PCV-2 infection alone, using infectious DNA clones of the virus or a ... Wasting pigs is the most common sign of PMWS infection, increasing the mortality rate significantly. François Madec, a French ...
Haemophilus influenzae b infections, and hepatitis B for premature infants. As of 2015, while failure to vaccinate is not ... Infections of the first two types are defined by Immunization Act [ja] (Japanese: 予防接種法) and its related cabinet order [ja] ( ... Compulsory vaccinations greatly reduce infection rates for the diseases they protect against. Common objections included the ... "Mandatory Influenza Vaccination of Healthcare Workers: A 5-Year Study". Infection Control and Hospital Epidemiology. 2010. Ro, ...
Haemophilus influenzae b infections, and hepatitis B for premature infants. As of 2015, while failure to vaccinate is not ... and the Head of the hospital infection and prevention committee. Mandatory immunization policies on BCG, diphtheria, tetanus, ...
... during Adaptation of Haemophilus influenzae to Chronic Lung Infection Associated with Chronic Obstructive Pulmonary Disease". ... "Biofilm-related infections of cerebrospinal fluid shunts". Clinical Microbiology and Infection. 12 (4): 331-337. doi:10.1111/j. ... In addition, he evaluated the issues associated with the biofilm infections in the orthopedic field for which he developed and ... "The Infection Connection - Exel: Drexel University's Research Magazine". "The Pathology Quarterly". path.upmc.edu. "Institute ...
Haemophilus influenzae (including β-lactamase-producing strains), Haemophilus parainfluenzae (including β-lactamase-producing ... Cefditoren, also known as cefditoren pivoxil is an antibiotic used to treat infections caused by Gram-positive and Gram- ... Haemophilus influenzae: ≥0.063 - 0.25 μg/ml Staphylcoccus aureus: 0.25 - >128 μg/ml (not includes methicillin-resistant ... Wellington K, Curran MP (2004). "Cefditoren pivoxil: a review of its use in the treatment of bacterial infections". Drugs. 64 ( ...
Typical bacterial Infections: Haemophilus influenzae Staphylococcus aureus Klebsiella pneumoniae Atypical bacterial Infections ... This total only accounts for Streptococcus pneumoniae and Haemophilus influenzae infections and does not account for atypical ... "Guidelines for the management of adult lower respiratory tract infections--full version". Clinical Microbiology and Infection. ... Lower respiratory tract infection (LRTI) is a term often used as a synonym for pneumonia but can also be applied to other types ...
... has been used to treat urinary tract infections and meningitis caused by Pseudomonas aeruginosa and Haemophilus ... While it is useful for many Gram negative infections, it is not useful for Gram positive infections. It can be given by ... Haemophilus influenzae: ≥0.8 μg/ml Pseudomonas aeruginosa: 0.25 μg/ml - 1 μg/ml An effective use of polymyxin B is found in ... Other serious side effects may include fungal infections, anaphylaxis, and muscle weakness. It is unclear if use during ...
... and infections caused by Haemophilus influenzae). Microgen is a Russian state company. Because of the special status of the ... infections and is resistant to antibiotics. Microgen started testing a new anti-tick vaccine for children. In 2011, Microgen ...
"DsrA-Deficient Mutant of Haemophilus ducreyi Is Impaired in Its Ability To Infect Human Volunteers". Infection and Immunity. 69 ... "Outer Membrane Protein DsrA Is the Major Fibronectin-Binding Determinant of Haemophilus ducreyi". Infection and Immunity. 76 (4 ... Cole, L. E.; Kawula, T. H.; Toffer, K. L.; Elkins, C. (2002). "The Haemophilus ducreyi Serum Resistance Antigen DsrA Confers ... White, C. D.; Leduc, I.; Olsen, B.; Jeter, C.; Harris, C.; Elkins, C. (2005). "Haemophilus ducreyi Outer Membrane Determinants ...
Haemophilus is the name of a group of bacteria that can cause serious disease, such as Hib. There is a vaccine to prevent Hib. ... ClinicalTrials.gov: Haemophilus Infections (National Institutes of Health) * ClinicalTrials.gov: Haemophilus influenzae type b ... Types of Haemophilus influenzae Infections (Centers for Disease Control and Prevention) Also in Spanish ... About Haemophilus influenzae Disease (Centers for Disease Control and Prevention) * Haemophilus Influenzae Type B (Hib): ...
Haemophilus influenzae is a small (1 µm X 0.3 µm), pleomorphic, gram-negative coccobacillus. ... encoded search term (Haemophilus Influenzae Infections) and Haemophilus Influenzae Infections What to Read Next on Medscape ... NTHi infection: 1.24 case per 100,000 population (NTHi infections accounted for 544 of the 822 H influenzae infection cases ... NTHi infection - 0.99 cases per 100,000 general population (NTHi infections accounted for 353 of the 551 H influenzae infection ...
Haemophilus Infections - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the MSD Manuals - Medical ... Prevention of Haemophilus Infections Hib conjugate vaccines Haemophilus influenzae Type b (Hib) Vaccine Haemophilus influenzae ... Vaccine Haemophilus influenzae type b conjugate vaccine helps prevent Haemophilus infections but not infections caused by other ... Vaccine Haemophilus influenzae type b conjugate vaccine helps prevent Haemophilus infections but not infections caused by other ...
For patient information about Haemophilus influenzae infection, click here , Haemophilus influenzae type b (Hib) vaccine, click ... Haemophilus influenza infections are caused by the bacterium Haemophilus influenza.. *It is a is a gram-negative, cocco- ... These infections can range from mild ear infections to severe diseases, like bloodstream infections. When the bacteria invade ... A larger bacterial load or the presence of a concomitant viral infection can potentiate the infection. ...
... of spectinomycin were determined for 66 strains of Haemophilus ducreyi, eight of which were beta lactamase producers. All ...
"Epidemiology of Haemophilus ducreyi Infections" 22, no. 1 (2016). González-Beiras, Camila et al. "Epidemiology of Haemophilus ... Bacteria Chancroid Epidemiology Epidemiology Of Haemophilus Ducreyi Infections Genital Ulcer Disease Genital Ulcers Haemophilus ... Title : Epidemiology of Haemophilus ducreyi Infections Personal Author(s) : González-Beiras, Camila;Marks, Michael;Chen, Cheng ... 2016). Epidemiology of Haemophilus ducreyi Infections. 22(1). González-Beiras, Camila et al. " ...
Haemophilus influenzae is a small (1 µm X 0.3 µm), pleomorphic, gram-negative coccobacillus. ... encoded search term (Haemophilus Influenzae Infections) and Haemophilus Influenzae Infections What to Read Next on Medscape ... Infections due to Haemophilus influenzae, other Haemophilus species, the HACEK group, and other gram-negative bacilli. ... Haemophilus Influenzae Infections Differential Diagnoses. Updated: Feb 16, 2016 * Author: Vidya R Devarajan, MD; Chief Editor: ...
Haemophilus influenzae type b Chapter of Pinkbook: (Epidemiology and Prevention of Vaccine-Preventable Diseases) ... Haemophilus influenzae infections. In: Kimberlin D, Brady M, Jackson M, et al., eds. Red Book: 2018 Report of the Committee on ... Haemophilus influenzae is a bacterium that causes often-severe infections, particularly among infants. It was first described ... Haemophilus influenzae type b (Hib). *Causes severe bacterial infection, particularly among infants ...
A publicly available article also appearing in PubMed about Haemophilus influenzae Infection ... Haemophilus influenzae disease is a name collectively used for any kind of infection caused by the bacteria called Haemophilus ... There are two types of infections caused by H. influenzae, invasive and non-invasive infections. The invasive Hib infection ... Pediatric invasive Haemophilus influenzae infections in Israel in the era of Haemophilus influenzae type b vaccine: a ...
Haemophilus. infection in COPD. Sofia Winslow, Lina Odqvist, Sarah Diver, Rebecca Riise, Suado Abdillahi, Cecilia Wingren, ... Haemophilus. infection in COPD. Eur Respir J, 58 (4) 2003312; 10.1183/13993003.03312-2020 You must login to share this ... Chlamydia pneumoniae enhances infection with Haemophilus influenzae, up-regulates TLR2-expression in human lung tissue and ... Nontypeable Haemophilus influenzae infection of human lung tissue induces proinflammatory cytokine response via toll-like ...
Haemophilus ducreyi, which causes the sexually transmitted disease chancroid, expresses a number of lipoproteins during human ... infection. One such lipoprotein, OmpP4, is homologous to the outer membrane lipoprotein e (P4) of H. influenzae. In H. ... Outer membrane protein P4 is not required for virulence in the human challenge model of Haemophilus ducreyi infection. *Diane M ... Outer membrane protein P4 is not required for virulence in the human challenge model of Haemophilus ducreyi infection ...
Categories: Haemophilus Infections Image Types: Photo, Illustrations, Video, Color, Black&White, PublicDomain, ...
With the high uptake in the uterus with 67Ga scintigraphy, she was diagnosed with invasive NTHi infection. In addition to ... the occurrence of invasive NTHi infection based on gynecologic diseases is still rare. A 51-year-old Japanese woman with a ... this case emphasizes the need to consider the uterus as a potential source of infection in patients with underlying ... The widespread administration of the Haemophilus influenzae type b vaccine has led to the predominance of non-typable H. ...
Haemophilus Infections. * Vaccine Information Statement (VIS) -- Haemophilus Influenzae Type b (Hib) Vaccine: What You Need to ... Rotavirus Infections. * Vaccine Information Statement (VIS) -- Rotavirus Vaccine: What You Need to Know - English PDF Vaccine ... Meningococcal Infections. * Vaccine Information Statement (VIS) -- Meningococcal ACWY Vaccine: What You Need to Know - English ... You Have TB Infection (A Type of TB) - Kreyol ayisyen (Haitian Creole) Bilingual PDF ...
... spectrum beta-lactam antibiotics as empirical treatment of Haemophilus influenzae-associated lower respiratory tract infections ... spectrum beta-lactam antibiotics as empirical treatment of Haemophilus influenzae-associated lower respiratory tract infections ... spectrum beta-lactam antibiotics as empirical treatment of Haemophilus influenzae-associated lower respiratory tract infections ... spectrum beta-lactam antibiotics as empirical treatment of Haemophilus influenzae-associated lower respiratory tract infections ...
Vaccines for diphtheria, tetanus, acellular pertussis, pneumococcal infections, Haemophilus influenzae type b, hepatitis B, ... 2010comvax-hepatitis-b-vaccine-haemophilus-influenzae-type-b-vaccine-343220. Drugs hepatitis b vaccine/haemophilus influenzae ...
Infections Caused by Haemophilus, Bordetella, Moraxella, and HACEK Group Organisms answers are found in the Harrisons Manual ... Haemophilus__Bordetella__Moraxella__and_HACEK_Group_Organisms. Chapter 92: Infections Caused By Haemophilus, Bordetella, ... "Chapter 92: Infections Caused By Haemophilus, Bordetella, Moraxella, and HACEK Group Organisms." Harrisons Manual of Medicine ... Chapter 92: Infections Caused by Haemophilus, Bordetella, Moraxella, and HACEK Group Organisms. In: Kasper DLD, Fauci ASA, ...
Haemophilus influenzae infection. 06/2021. Hantavirus Pulmonary Syndrome. 12/2018. Hepatitis A. 02/2019. ...
Haemophilus influenzae increases the susceptibility and inflammatory response of airway epithelial cells to viral infections. ... Haemophilus influenzae increases the susceptibility and inflammatory response of airway epithelial cells to viral infections. ... Haemophilus influenzae increases the susceptibility and inflammatory response of airway epithelial cells to viral infections. ... Haemophilus influenzae increases the susceptibility and inflammatory response of airway epithelial cells to viral infections. ...
Moxalactam treatment of serious infections primarily due to Haemophilus influenzae type b in children. Pediatrics. 1983 Mar 24; ... Moxalactam treatment of serious infections primarily due to Haemophilus influenzae type b in children. In: Pediatrics. 1983 ; ... Dive into the research topics of Moxalactam treatment of serious infections primarily due to Haemophilus influenzae type b in ... Moxalactam treatment of serious infections primarily due to Haemophilus influenzae type b in children. / Kaplan, Sheldon; Mason ...
"Haemophilus influenzae type a infection and its prevention". Infection and Immunity. 75 (6): 2650-2654. doi:10.1128/IAI.01774- ... "Haemophilus Influenzae Infections: Practice Essentials, Background, Pathophysiology". Medscape. "Haemophilus Influenzae". ... eye infections and bloodstream infection, meningitis. It can also cause cellulitis (skin infection) and infectious arthritis ( ... Haemophilus influenzae can cause respiratory tract infections including pneumonia, otitis media, epiglottitis (swelling in the ...
... of Streptococcus pneumoniae and Haemophilus infuenzae susceptibilities from community-acquired respiratory tract infections and ... Comparison of Streptococcus pneumoniae and Haemophilus infuenzae,/i> susceptibilities from community-acquired respiratory tract ... infections and hospitalized patients with pneumonia: Five-year results for the SENTRY Antimicrobial Surveillance Program. by ...
Diabetes Prevalence in the US, Invasive Nontypeable Haemophilus influenzae Infection in HIV-Infected Adults, Diagnosis and ... Diabetes Prevalence in the US, Invasive Nontypeable Haemophilus influenzae Infection in HIV-Infected Adults, Diagnosis and ...
S. pneumoniae pneumonia mice were supplemented with or without all-trans retinoic acid 24 hours after infection. Vitamin A ... pneumoniae pneumonia mice were lower than 0.7µmol/L from day 2-7 post infection, while pulmonary vitamin A productions were ... significantly lower than those in the control mice from day 7-28 post infection. Vitamin A supplement after neonatal S. ... Our previous study showed that neonatal Streptococcus pneumoniae (S. pneumoniae) infection promoted asthma development. Whether ...
  • Streptococcus pneumoniae and Haemophilus influenzae are the most common bacteria causing pneumonia and these two organisms account for more than half of all deaths due to pneumonia in children under five years of age. (who.int)
  • vaccination, including use of vaccines against infection by Streptococcus pneumoniae and Haemophilus influenzae type b · case management of pneumonia in the community, health centres and hospitals · exclusive breastfeeding for the first six months of life · improvement of nutrition and prevention of low birth weight · control of indoor air pollution and provision of a healthy environment · prevention and management of HIV infection. (who.int)
  • Vaccination against Streptococcus pneumoniae and Haemophilus influenzae type b (Hib) infections has reduced the incidence of pneumonia in various settings by about 30% (range 20% to 37%) and 20% (range 12% to 55%), respectively. (who.int)
  • Comparison of Streptococcus pneumoniae and Haemophilus infuenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: Five-year results for the SENTRY Antimicrobial Surveillance Program. (jmilabs.com)
  • Our previous study showed that neonatal Streptococcus pneumoniae ( S. pneumoniae ) infection promoted asthma development. (nature.com)
  • Use of EMPAVELI may predispose individuals to serious infections, especially those caused by encapsulated bacteria, such as Streptococcus pneumoniae, Neisseria meningitidis types A, C, W, Y, and B, and Haemophilus influenzae type B [see WARNINGS AND PRECAUTIONS]. (rxlist.com)
  • The micro organism that is most often answerable for irritation and sphenoid sinus infection is Streptococcus pneumonia. (regressiveantidote.net)
  • The three most common bacteria that cause middle ear infections are Haemophilus influenzae , Streptococcus pneumoniae and Moraxella catarrhalis . (theconversation.com)
  • Interestingly, before we had pneumococcal vaccines against Streptococcus pneumoniae , these bacteria caused about 60%-70% of all ear infections in children between 6 months and 5 years of age. (theconversation.com)
  • Haemophilus influenzae type b, Streptococcus pneumoniae , and Neisseria meningitidis colonise the mucosa of the human upper respiratory tract along with other opportunistic pathogens and commensal bacteria. (bmj.com)
  • The virus-infected cells were harvested at various times after infection and analyzed for the ability to bind strains of Haemophilus influenzae and Streptococcus pneumoniae. (lu.se)
  • All of the serotypes, particularly type b, are common etiological agents in lower respiratory tract infections such as pneumonia. (statpearls.com)
  • Bacterial infections contribute disproportionately to pneumonia mortality in developing countries. (who.int)
  • Although bacterial infections account for no more than 50% of cases of pneumonia, they cause nearly 70% of deaths due to pneumonia. (who.int)
  • Deaths due to pneumonia that occur during the neonatal period and those that are associated with measles, pertussis and HIV infection are not included in this figure. (who.int)
  • H. influenzae is responsible for a wide range of localized and invasive infections, typically in infants and children, including pneumonia, meningitis, or bloodstream infections. (wikipedia.org)
  • S. pneumoniae pneumonia mice were supplemented with or without all-trans retinoic acid 24 hours after infection. (nature.com)
  • We stated that serum vitamin A levels in neonatal S. pneumoniae pneumonia mice were lower than 0.7µmol/L from day 2-7 post infection, while pulmonary vitamin A productions were significantly lower than those in the control mice from day 7-28 post infection. (nature.com)
  • Haemophilus influenzae type b (Hib) is bacteria that commonly cause bacterial meningitis and pneumonia and the leading cause of other invasive diseases as septic arthritis (joint infection), epiglottitis (infection and swelling of the epiglottis) and cellulites (rapidly progressing skin infection which usually involves face, head, or neck). (who.int)
  • And Glaxo-Smith-Kline has a vaccine that has ten important serotypes and an important cause of pneumonia and ear infections called Haemophilus influenza. (voanews.com)
  • The bacteria also brings on blood infections, meningitis, and pneumonia. (tutorialspoint.com)
  • Meningitis, pneumonia, ear infections, and blood infections can all be brought on by this bacteria. (tutorialspoint.com)
  • This bacteria is responsible for toxic shock syndrome, pneumonia, and skin infections. (tutorialspoint.com)
  • They can also cause many other types of serious infections such as meningitis, epiglottitis, cellulitis, septic arthritis, and even empyema and bacteremia. (statpearls.com)
  • Meningitis is an infection of the lining of the brain and spinal cord. (healthychildren.org)
  • Meningococcal infections may occur in patients treated with EMPAVELI and may become rapidly life-threatening or fatal if not recognized and treated early. (rxlist.com)
  • This report describes case notification data for measles, pertussis, rubella, Haemophilus influenzae type b invasive infection, invasive meningococcal disease (IMD), mumps, tetanus and invasive pneumococcal disease (IPD) in NSW, Australia, in 2012 and provides comparison with recent trends. (who.int)
  • Based on the success of Haemophilus influenzae type b conjugate vaccines, chemical conjugation has been applied to the development of pneumococcal and meningococcal polysaccharide conjugate vaccines. (bmj.com)
  • Infections like meningococcal, Haemophilus influenza, pneumococcal, streptococcal and E. coli infections are most common. (nethealthbook.com)
  • In recent years there has been the addition of several vaccines (pneumococcal vaccine, meningococcal vaccine, haemophilus vaccine), which help the immune system to cope with pneumococcal, meningococcal and haemophilus infections. (nethealthbook.com)
  • Zoonotic Bacterial Respiratory Infections Associated With Cats and Dogs: A Case Series and Literature Review. (moffitt.org)
  • Because these are associated with viral upper respiratory infections, we typically see most ear infections in the fall and winter, when influenza and cold viruses are prevalent. (theconversation.com)
  • However, with near-universal mask-wearing due to COVID-19 last winter and many children out of school, the number of viral upper respiratory infections dropped drastically . (theconversation.com)
  • Several new mucosal vaccines against respiratory infections are under development. (bmj.com)
  • harrisons.unboundmedicine.com/harrisons/view/Harrisons-Manual-of-Medicine/623234/all/Chapter_92:_Infections_Caused_by_Haemophilus__Bordetella__Moraxella__and_HACEK_Group_Organisms. (unboundmedicine.com)
  • A small percentage develop secondary bacterial infection with streptococci, pneumococci, Haemophilus influenzae , Moraxella catarrhalis, or staphylococci. (merckmanuals.com)
  • Haemophilus ducreyi infection induces activation of the NLRP3 inflammasome in nonpolarized but not in polarized human macrophages. (iu.edu)
  • The cost-effectiveness of the Haemophilus influenzae type b and pneumococcal vaccines depends on the burden of disease and the price of vaccines in the country concerned. (who.int)
  • The introduction of Haemophilus influenzae type b conjugate vaccines during the 1990s was followed by dramatic decreases both in the incidence of Haemophilus influenzae type b related invasive disease and in nasopharyngeal carriage of the organism. (bmj.com)
  • The extent of this effect has been influenced by the fact that Haemophilus influenzae type b conjugate vaccines reduce nasopharyngeal carriage and induce herd immunity. (bmj.com)
  • This article reviews recent studies on mucosal immune responses induced by polysaccharide based vaccines and some protein vaccine antigens against several pathogenic nasopharyngeal bacteria, and discusses the mechanisms and functions of these immune responses that may help our understanding of mucosal immune responses to both immunisation and infection. (bmj.com)
  • It is also difficult to understand the importance of new vaccines that target illnesses that many know little about, like a vaccine to prevent infection by the sexually-transmitted human papillomaviruses (HPV). (immunizationinfo.org)
  • Natural risks (such as infections for which there are no vaccines) are better tolerated than manmade risks (such as vaccine side effects). (immunizationinfo.org)
  • Haemophilus influenzae Type b (Hib) Vaccine Haemophilus influenzae type b conjugate vaccine helps prevent Haemophilus infections but not infections caused by other strains of H. influenzae bacteria. (msdmanuals.com)
  • Occasionally, nonencapsulated strains cause invasive infections in children, but they may cause up to half of serious H. influenzae infections in adults. (msdmanuals.com)
  • Using an agar dilution technique with standardised inocula prepared by ultrasonication, the minimum inhibitory concentrations (MICs) of spectinomycin were determined for 66 strains of Haemophilus ducreyi, eight of which were beta lactamase producers. (bmj.com)
  • They can also help to differentiate true NTHi from Haemophilus haemolyticus and from those H. influenzae strains that possess a complete or partial capsule focus. (statpearls.com)
  • Haemophilus influenzae type b (seven ampicillin-resistant strains) was the etiologic agent for 32 children. (houstonmethodist.org)
  • Nontypeable strains are rare causes of serious infection among children but are a common cause of ear infections in children and bronchitis in adults. (who.int)
  • Strep strains A, B, and C. The ailments that this bacterial group can cause range from blood infections to strep throat. (tutorialspoint.com)
  • Adenovirus (types 1, 2, 3, and 5) commonly causing respiratory tract infections increased the binding of adherent S. pneumoniae strains to the cells. (lu.se)
  • Adenovirus infection did not change the adherence of cells of poorly adhering strains of S. pneumoniae or H. influenzae. (lu.se)
  • Epiglottitis Epiglottitis is a rapidly progressive bacterial infection of the epiglottis and surrounding tissues that may lead to sudden respiratory obstruction and death. (msdmanuals.com)
  • Treatment of suspected bacterial infection is with antibiotics, such as amoxicillin /clavulanate or doxycycline , given for 5 to 7 days for acute sinusitis and for up to 6 weeks for chronic sinusitis. (merckmanuals.com)
  • Haemophilus influenzae type b (Hib) bacterial infection was the most frequent cause of epiglottitis in youngsters. (tutorialspoint.com)
  • The increased attachment may be one mechanism by which viruses precondition the respiratory mucosa for bacterial infection. (lu.se)
  • The global epidemiology of Haemophilus ducreyi infections microbiological diagnoses. (cdc.gov)
  • Current epidemiology and trends in invasive Haemophilus influenzae disease--United States, 1989-2008. (medscape.com)
  • To have better insights into this complex infectious disease, the current mini-review illustrates a brief description of tetanus and its history, latest statistics, and its types followed by pathogenesis which includes causes, and mechanisms of infection. (pediatriconcall.com)
  • Further understanding of the disease by research communities will help in eradicating tetanus and also equipped clinicians with a better management approach against this deadly infection which is simply much more complex to be understood. (pediatriconcall.com)
  • Tetanus is a type of infection disorder that demands immediate attention and treatment. (pediatriconcall.com)
  • Haemophilus is the name of a group of bacteria. (medlineplus.gov)
  • Infective Endocarditis Infective endocarditis is infection of the endocardium, usually with bacteria (commonly, streptococci or staphylococci) or fungi. (msdmanuals.com)
  • However, the bacteria can sometimes move to other parts of the body and cause infection. (wikidoc.org)
  • Neonates can acquire the infection by aspiration of amniotic fluid or contact with genital tract secretions containing the bacteria. (wikidoc.org)
  • Haemophilus influenzae is a bacteria characterized as a small, facultatively anaerobic, pleomorphic, and capnophilic gram-negative coccobacillus of the family Pasteurellaceae. (statpearls.com)
  • Haemophilus influenzae disease is a name collectively used for any kind of infection caused by the bacteria called Haemophilus influenzae . (statpearls.com)
  • Dual infections with bacteria and viruses are associated with high mortality. (who.int)
  • Elizabeth Briere] Haemophilus influenza, or Hi, are bacteria that can cause a variety of infections in children and adults. (cdc.gov)
  • Vaccinate patients against encapsulated bacteria as recommended at least 2 weeks prior to administering the first dose of EMPAVELI unless the risks of delaying therapy with EMPAVELI outweigh the risk of developing a serious infection. (rxlist.com)
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline for injection, USP and other antibacterial drugs, doxycycline for injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. (nih.gov)
  • Hib bacteria can cause mild illness, such as ear infections or bronchitis, or they can cause severe illness, such as infections of the bloodstream. (healthychildren.org)
  • A larger bacterial load or the presence of a concomitant viral infection can potentiate the infection. (wikidoc.org)
  • Clinical features may include initial symptoms of an upper respiratory tract infection mimicking a viral infection, usually associated with low-grade fevers. (wikipedia.org)
  • Furthermore, hi-NTHI pretreatment may enhance the inflammatory response to RSV infection, suggesting that preexisting bacterial infections might exaggerate inflammation during secondary viral infection. (maastrichtuniversity.nl)
  • The viral infection Haemophilus influenza can even spurn sphenoidal sinus ache. (regressiveantidote.net)
  • This acute clinical picture can also happen in a patient with a severe course of mononucleosis (Epstein-Barr viral infection). (nethealthbook.com)
  • One common type, Hib (Haemophilus influenzae type b), causes serious disease. (medlineplus.gov)
  • Haemophilus influenzae type b (Hib) vaccine, click here . (wikidoc.org)
  • Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. (medscape.com)
  • The continuing role of Haemophilus influenzae type b carriage surveillance as a mechanism for early detection of invasive disease activity. (medscape.com)
  • Haemophilus influenzae type a infection and its prevention. (medscape.com)
  • The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease. (medscape.com)
  • The Hib conjugate vaccine is effective for protection against capsular polysaccharide type 'b' and has decreased the rate of Hib infections to a greater extent. (statpearls.com)
  • The widespread administration of the Haemophilus influenzae type b vaccine has led to the predominance of non-typable H. influenzae (NTHi). (biomedcentral.com)
  • Although H. influenzae type b (Hib) is a notoriously virulent serotype of this species [ 4 ], the introduction of routine conjugate Hib vaccination led to a decrease in the number of cases of Hib infection [ 5 ]. (biomedcentral.com)
  • In Japan, a recent nationwide population-based surveillance study revealed that NTHi and H. influenzae type f became the predominant isolates associated with invasive H. influenzae infection after the introduction of the Hib vaccine [ 10 ]. (biomedcentral.com)
  • All children with infections due to H influenzae type b had excellent responses to moxalactam therapy. (houstonmethodist.org)
  • Moxalactam administered parenterally, at a dose of 113 to 150 mg/kg/d in three or four divided doses is effective therapy for serious infections in children due to H influenzae type b and selected other organisms. (houstonmethodist.org)
  • Prevents infections caused by hepatitis B virus and Haemophilus influenzae type b virus. (stlukes-stl.com)
  • Tell your doctor if your child has any type of illness or infection (such as a cold or the flu), especially if your child has a fever. (stlukes-stl.com)
  • invasive infections caused by Haemophilus influenzae type b (DTPa-hepB-IPV-Hib). (health.gov.au)
  • Hib vaccine can prevent Haemophilus influenzae type b (Hib) disease . (healthychildren.org)
  • Haemophilus influenzae type b can cause many different kinds of infections. (healthychildren.org)
  • DNA from a 6th century boy's tooth reveals signs of the earliest known Haemophilus influenzae type b infection, shedding light on the pathogen's history. (sciencenews.org)
  • There were no Haemophilus influenzae type b case notifications in children less than five years of age for the first time since the vaccine was introduced. (who.int)
  • For example, in 2008 three unimmunized children in Minnesota developed invasive disease due to Haemophilus influenzae, type B (Hib) infection. (immunizationinfo.org)
  • For example, people tolerate far less risk from the vaccine used to prevent infection with Haemophilus influenzae type b than they do the antibiotics that are used to treat the infections it causes. (immunizationinfo.org)
  • In the past, infection with the Haemophilus influenzae type b (Hib) bacterium was a frequent cause of swelling and inflammation of the epiglottis and adjacent tissues. (tutorialspoint.com)
  • Children who miss immunizations or wait too long to obtain them run the risk of developing epiglottitis and being susceptible to Haemophilus influenzae type b (Hib). (tutorialspoint.com)
  • According to the Centers for disease control and prevention (CDC), approximately 10 to 20 percent of infections are fatal. (pediatriconcall.com)
  • However, the occurrence of invasive NTHi infection based on gynecologic diseases is still rare. (biomedcentral.com)
  • With the high uptake in the uterus with 67 Ga scintigraphy, she was diagnosed with invasive NTHi infection. (biomedcentral.com)
  • Although NTHi bacteremia consequent to a microabscess in adenomyosis is rare, this case emphasizes the need to consider the uterus as a potential source of infection in patients with underlying gynecological diseases, including an invasive NTHi infection with no known primary focus. (biomedcentral.com)
  • While previous reports have established the urogenital tract as a potential cause of invasive H. influenzae infection, no reports have described a specific association of NTHi infection with adenomyoma. (biomedcentral.com)
  • Here, we report a case of invasive NTHi infection associated with a massive adenomyosis in an immunocompetent Japanese woman. (biomedcentral.com)
  • Nontypeable Haemophilus influenzae (NTHI), a common colonizer of lungs of patients with chronic obstructive pulmonary disease (COPD), can enhance expression of the cellular receptor intercellular adhesion molecule 1 (ICAM-1), which in turn can be used by major group human rhinoviruses (HRVs) for attachment. (maastrichtuniversity.nl)
  • Interestingly, release of IL-6 and IL-8 after RSV, but not HRV, infection was synergistically increased in hi-NTHI-pretreated BEAS-2B cells. (maastrichtuniversity.nl)
  • H.influenzae is a gram-negative , cocco-bacillary , facultatively anaerobic pathogenic bacterium that can cause infections in people of all ages ranging from mild, such as an ear infection, to severe, such as a bloodstream infection. (wikidoc.org)
  • Haemophilus influenza infections are caused by the bacterium Haemophilus influenza . (wikidoc.org)
  • Haemophilus influenzae is a bacterium that causes often-severe infections, particularly among infants. (cdc.gov)
  • There is consensus that definitive therapy for infections with H. influenzae should include antimicrobial agents with clinical breakpoints against the bacterium. (lu.se)
  • Haemophilus influenzae (formerly called Pfeiffer's bacillus or Bacillus influenzae) is a Gram-negative, non-motile, coccobacillary, facultatively anaerobic, capnophilic pathogenic bacterium of the family Pasteurellaceae. (wikipedia.org)
  • This obscure bacterium causes a severe infection for which almost no treatments exist, and mainly affects people who are already critically ill. (bioedonline.org)
  • Ear pain is one of the most common reasons that young children go to the doctor, and acute otitis media - which means "middle ear infection" - is the most frequent cause for the use of antibiotics in children under 5 years of age. (theconversation.com)
  • Acute otitis media is typically treated with antibiotics, which are generally recommended for ear infections in children younger than age 2. (theconversation.com)
  • Your child should not receive this vaccine if he or she has had an allergic reaction to Haemophilus b conjugate vaccine, hepatitis B vaccine, or yeast. (stlukes-stl.com)
  • Susceptibility of Haemophilus ducreyi to spectinomycin in vitro. (bmj.com)
  • In the absence of fever or if the infection is on only one side, the recommendation is to wait a day or two before starting antibiotics, as sometimes these infections will clear on their own in older children. (theconversation.com)
  • These infections can range from mild ear infections to severe diseases, like bloodstream infections. (wikidoc.org)
  • Haemophilus influenzae is a small (1 µm × 0.3 µm), pleomorphic, gram-negative coccobacillus. (medscape.com)
  • Haemophilus influenzae is characterized as a small (0.3 micrometer to 1 micrometer), facultatively anaerobic, pleomorphic, and capnophilic gram-negative coccobacillus of the family Pasteurellaceae . (statpearls.com)
  • Identify the pathophysiology of Haemophilus influenza infections. (statpearls.com)
  • The capsule of H influenza plays a key role in the pathogenesis of the all the capsulated H influenza infections. (wikidoc.org)
  • Summarize the treatment considerationsfor Haemophilus influenza infections. (statpearls.com)
  • Diagnosis of Haemophilus infections is by culture of blood and body fluids. (msdmanuals.com)
  • Haemophilus ducreyi , a fastidious gram-negative bac- Methods terium, is the causative agent of chancroid, a genital ulcer disease (GUD). (cdc.gov)
  • Bacterial infections that may result in epiglottitis can be more common in people with immune systems that have been compromised by disease or medication. (tutorialspoint.com)
  • Overcrowded living conditions and day care center attendance predispose to infection, as do immunodeficiency states, asplenia, and sickle cell disease. (msdmanuals.com)
  • Treatment of Haemophilus infections depends on nature and location of the infection, but, for invasive disease, beta-lactam/beta-lactamase inhibitors, fluoroquinolones, and 2nd- and 3rd-generation cephalosporins are used. (msdmanuals.com)
  • Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009. (medscape.com)
  • Haemophilus Influenzae serotype b (Hib) disease. (medscape.com)
  • Severe Hib infection, also called invasive Hib disease, requires treatment in a hospital and can sometimes result in death. (healthychildren.org)
  • pericardiatis (infection of the sac covering the heart) and Osteomyelitis (bone infection) are less common forms of invasive disease. (who.int)
  • Fifth disease is a common infection in children aged 4 to 10. (uniprix.com)
  • Vaccine-preventable disease control is continually strengthening in NSW with notable successes in invasive bacterial infections. (who.int)
  • See WARNINGS AND PRECAUTIONS for additional guidance on the management of the risk of serious infections. (rxlist.com)
  • Vaccination reduces, but does not eliminate, the risk of serious infections. (rxlist.com)
  • Monitor patients for early signs of serious infections and evaluate immediately if infection is suspected. (rxlist.com)
  • Chancroid Chancroid is infection of the genital skin or mucous membranes caused by Haemophilus ducreyi and characterized by papules, painful ulcers, and enlargement of the inguinal lymph nodes. (msdmanuals.com)
  • Carbon storage regulator A contributes to the virulence of Haemophilus ducreyi in humans by multiple mechanisms. (iu.edu)
  • Capsule gene analysis of invasive Haemophilus influenzae: accuracy of serotyping and prevalence of IS1016 among nontypeable isolates. (medscape.com)
  • It is an allergic response to the presence of topical fungi, often Aspergillus, and is not caused by an invasive infection. (merckmanuals.com)
  • In conclusion, despite early clinical response rates being slightly lower for benzylpenicillin compared to WSBL, we found no support for increased mortality or readmission rates in patients empirically treated with benzylpenicillin for lower respiratory tract infections by H. influenzae. (lu.se)
  • and urinary tract infections Urinary Tract Infection (UTI) in Children Urinary tract infection (UTI) is defined by ≥ 5 × 10 4 colonies/mL in a catheterized urine specimen or, in older children, by repeated voided specimens with ≥ 10 5 colonies/mL... read more , may occur in adults, although far less commonly. (msdmanuals.com)
  • Following recommended childhood vaccination schedules is a big part of preventing ear infections, or at least decreasing their frequency. (theconversation.com)
  • Doxycycline has been shown to be active against most isolates of the following microorganisms, both in vitro and in clinical infections (see INDICATIONS AND USAGE). (nih.gov)
  • Clinically, patients have atopic symptoms (especially asthma ) and present with recurrent chest infections. (radiopaedia.org)
  • When you follow the immunization schedule to protect your child and watch out for symptoms of other common infections, you generally don't need to worry about childhood diseases. (uniprix.com)
  • One complication following a splenectomy that the patient is more susceptible to certain bacterial infections. (nethealthbook.com)
  • Lack of awareness of the seriousness of vaccine-preventable diseases, in large measure a result of the remarkably low incidences of these infections. (contemporarypediatrics.com)

No images available that match "haemophilus infections"